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ABSTRACT 
 
More than 20 million infants in the world (15.5 % of all births) are born with low birth 
weight. Ninety-five % of them are in developing countries. Oral colonization of Gram-
negative anaerobes has been implicated as a risk factor for preterm delivery of low birth 
weight (PLBW) infants. The objective of this study was to investigate the association 
between periodontal pathogens and pre-term delivery of low birth weight (PLBW) 
infants. The study sample included 200 randomly selected women admitted to the 
department of obstetrics-gynecology of the teaching hospital of Butare in Rwanda. 
Mothers were asked to complete a questionnaire in order to identify factors which might 
pose a health risk to them and their infants. Gingival crevicular fluid (GCF) was collected 
from each quadrant of the mother’s month (using paper points) within 24 hours of 
delivery. Ten ml of foetal cord serum samples were collected at delivery and 10 ml of 
maternal serum samples were collected within 48 of delivery. GCF was examined by 
PCR for the presence of 5 periodontopathogens and ELISA was used for the evaluation of 
cytokines (IL-6 and IL-10) and immunoglobulins (IgM, IgG) in foetal cord and maternal 
blood against the periodontopathogens. P. intermedia showed significant associations 
either on its own or in combinations with most indicators of periodontal disease used in 
this study, while Aa and members of the red complex were significantly associated with 
gum bleeding and reduced frequency of tooth brushing. A strong association between 
PLBW and maternal and foetal cord serum sample levels of IL-10 was observed. Also, a 
good association was observed between PLBW and FCB sample levels of IL-6. 
Significant associations were observed between PLBW and maternal IgG against the 
different peridontopathogens. The findings of this study may suggest that the levels of 
maternal IgG and foetal IgM against the different periodontopathogens are associated 
with dissemination of maternal periodontopathogens to the foetus thereby illiciting an 
inflammatory response which contributes to PLBW. 
 
 
 
 
 
 
 iv
DECLARATION 
 
 
I declare that this work is my own work, that it has not been submitted 
before for any degree or examination in any other university, and that all the 
sources I have used or quoted have been indicated and acknowledged by 
complete references. 
 
 
 
Claude BAYINGANA                                                                            October 2010 
 
 
 
Signed:…………………….. 
 
 
 
 
 
 
 
 
 
 
 v
PEER REVIEWED ARTICLES PUBLISHED FROM THIS STUDY  
 
1. COMPARISON OF PCR AND BANA HYDROLYSIS IN THE DETECTION OF 
ORAL ANAEROBES IN SUBGINGIVAL PLAQUE. 
 African Journal of Microbiology Research 2010; 4(9): 771-774 (See abstract, appendix 
G) 
------------------------------------------------------------------------------------------------------------ 
2. EXAMINATION OF MATERNAL GINGIVAL CREVICULAR FLUID FOR THE 
PRESENCE OF SELECTED PERIODONTOPATHOGENS IMPLICATED IN THE 
PRE-TERM DELIVERY OF LOW BIRTHWEIGHT INFANTS. 
 Virulence 2010; 1(4): 1-6 July/August  (See abstract, appendix H). 
------------------------------------------------------------------------------------------------------------ 
3. RISK FACTORS WHICH MAY INFLUENCE PRETERM DELIVERY OF LOW 
BIRTH WEIGHT (PLBW) IN AN AFRICAN POPULATION. 
Journal of Clinical Medicine and Research 2010; 2(7): 114-118 (See abstract, appendix 
I). 
 
 
 
 
 
 
 
 
 
 vi
AKNOWLEDGEMENTS 
 
I would like to thank: 
 
Prof Charlene W.J. Africa for her advice, patience, commitment and quest for perfection 
throughout the guidance of this study. 
My wife and children whose support and love continues to inspire me. 
My parents for their unreserved encouragement. 
Mr. Jérôme Karangwa for his permanent support for all my initiatives 
Rwandan government and NRF for financial assistance. 
The department of Medical Biosciences for all kind of assistance in this study. 
Dr Claude Sibomana, Dr Janet Kayitenkore and all the staff of the department of 
obstetric-gynecology of the teaching hospital of Butare in Rwanda for their co-operation 
and assistance in patient selection and sample collection. 
All pregnant women for their willing co-operation in the study. 
Prof Ed Pool and his students for their assistance in the immunology laboratory. 
Mr. Theogene Bahizi for his assistance in sample collection and the management of all 
the questionnaires. 
Mr. Norman Coldrey, Mr. Ernest Moboza and all Prof Africa’s PhD and masters students 
for their assistance in the laboratory. 
All my friends and relatives who contributed directly or indirectly to this study. 
 
 
 
 
 
 
 vii
 
 
 
 
 
 
 
 
DEDICATION 
 
I dedicate this thesis to my wife and children for their love, sacrifice and 
patience for my success. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii
Table of Contents 
KEYWORDS: .......................................................................................................................... ii 
ABSTRACT ............................................................................................................................ iii 
DECLARATION .................................................................................................................... iv 
PEER REVIEWED ARTICLES PUBLISHED FROM THIS STUDY ............................... v 
AKNOWLEDGEMENTS ...................................................................................................... vi 
DEDICATION ....................................................................................................................... vii 
TABLE OF CONTENTS ..................................................................................................... viii 
LIST OF TABLES ................................................................................................................... x 
LIST OF FIGURES ................................................................................................................ xi 
LIST OF ABREVIATIONS USED IN THIS STUDY ....................................................... xii 
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW ..................................... 1 
1.1. BACKGROUND: ......................................................................................................... 1 
1.2. PRE-TERM DELIVERY AND LOW BIRTH WEIGHT INFANTS ....................... 2 
1.3. EXPLORING THE ROLE OF PERIODONTAL INFECTIONS ............................. 4 
1.3.1. Background ................................................................................................................ 4 
1.3.2. The host immunological response in periodontal disease ...................................... 8 
1.3.3. Role of cytokines in PLBW and their proposed mechanism of action: ............... 10 
1.4. HYPOTHESIS: ......................................................................................................... 122 
1.5. OBJECTIVES: .......................................................................................................... 133 
CHAPTER 2: MATERIALS AND METHODS ................................................................ 144 
2.1. PATIENT SELECTION........................................................................................... 144 
2.2. CLINICAL EXAMINATION AND SAMPLE COLLECTION ........................... 155 
2.2.1. Oral examination and gingival crevicular fluid (GCF) sample collection ......... 155 
2.2.2. Blood sample collection ........................................................................................ 166 
2.3. EVALUATION OF IL-6 AND IL-10 LEVELS USING ELISA .......................... 166 
2.3.1. ELISA test protocol ............................................................................................... 166 
2.3.2. Calculation of results ............................................................................................ 188 
2.4. ESTIMATION OF MATERNAL SERUM IgG AND FOETAL CORD IgG ..... 188 
2.4.1. Bacterial strains used and preparation of bacterial antigens .............................. 188 
2.4.2. ELISA assay .......................................................................................................... 199 
2.5. 16S rRNA GENE DETECTION BY PCR.............................................................. 211 
2.5.1. Sample preparation ............................................................................................... 211 
2.5.2. Preparation of reference DNA .............................................................................. 222 
2.5.3. PCR amplification ................................................................................................. 233 
2.6. DATA ANALYSIS .................................................................................................. 266 
CHAPTER 3: RISK FACTORS ASSOCIATED WITH PLBW AS ASSESSED FROM 
THE QUESTIONNAIRE .................................................................................................... 288 
3.1. INTRODUCTION .................................................................................................... 288 
3.2. PERSONAL DETAILS OF MOTHERS ................................................................ 288 
3.3. MEDICAL HISTORY OF THE MOTHERS ......................................................... 311 
3.4. HISTORY OF PREVIOUS DELIVERIES ............................................................... 35 
3.5. LIVING CONDITIONS ........................................................................................... 366 
3.6. DENTAL HISTORY OF THE MOTHER .............................................................. 388 
3.7. DISCUSSION ............................................................................................................. 40 
 
 
 
 
 ix
CHAPTER 4: PCR DETECTION OF SUSPECTED PERIODONTOPATHOGENS  IN 
GINGIVAL CREVICULAR FLUID .................................................................................. 444 
4.1. INTRODUCTION .................................................................................................... 444 
4.2. PREVALENCE OF THE FIVE SUSPECTED PERIODONTOPATHOGENS IN 
GCF AS DETECTED BY PCR ...................................................................................... 455 
4.3. ASSOCIATION BETWEEN AGE AND THE FIVE 
PERIODONTOPATHOGENS ....................................................................................... 511 
4.4. CORRELATION BETWEEN LEVELS OF EDUCATION AND THE FIVE.... 533 
PERIODONTOPATHOGENS ....................................................................................... 533 
4.5. CORRELATION BETWEEN DENTAL HISTORY AND THE FIVE ............... 555 
PERIODONTOPATHOGENS ....................................................................................... 555 
4.6. CORRELATION BETWEEN SMOKING, ALCOHOL CONSUMPTION AND 
THE FIVE PERIODONTOPATHOGENS .................................................................... 599 
4.7. CORRELATION BETWEEN CLINICAL SIGNS OF GINGIVAL 
INFLAMMATION AND THE FIVE PERIODONTOPATHOGENS .......................... 60 
4.8. CORRELATION BETWEEN THE FIVE PERIODONTOPATHOGENS AND 
PREGNANCY OUTCOMES ......................................................................................... 622 
4.9. DISCUSSION ........................................................................................................... 633 
CHAPTER 5: EVALUATION OF IL-6 AND IL-10 LEVELS IN MATERNAL AND 
FOETAL CORD SAMPLES ............................................................................................... 677 
5.1. INTRODUCTION .................................................................................................... 677 
5.2. IL-10 AND IL-6 RESULTS .................................................................................... 699 
5.3. DISCUSSION ........................................................................................................... 777 
CHAPTER 6: EVALUATION OF IgG AND IgM LEVEL AGAINST FIVE 
PERIODONTOPATHOGENS ............................................................................................ 822 
6.1. INTRODUCTION .................................................................................................... 822 
6.2. IgG AND IgM RESULTS ........................................................................................ 844 
    6.3. DISCUSSION…………………………………………………………………….90 
CHAPTER 7: SUMMARY AND CONCLUSION ........................................................... 933 
REFERENCES ................................................................................................................... 1044 
 
 
 
 
 
 
 x
List of Tables  
Table 1: Bacterial clusters described by Socransky et al (1998). ......................................... 6 
Table 2. Illustration of ELISA standards and sample disposition. .................................... 177 
Table 3. Illustration of ELISA for IgG and IgM’s ............................................................... 20 
Table 4: PCR primer sequences used for  detection of our target bacteria....................... 244 
Table 5: Components of the PCR reaction ......................................................................... 255 
Table 6: Details of Mothers ................................................................................................... 30 
Table 7: Medical History of the Mothers ........................................................................... 322 
Table 8: History of Previous Deliveries ............................................................................. 355 
Table 9: Conditions of life in the house .............................................................................. 377 
Table 10: Dental History of the Mother.............................................................................. 388 
Table 11: Prevalence of the five suspected peridontopathogens in maternal GCF.......... 477 
Table 12: Correlation between age and the five anaerobic periodontopathogens ........... 522 
Table 13: Correlation between level of education and the five periodontopathogens ..... 544 
Table 14: Correlation between frequency of tooth brushing and the five 
periodontopathogens. ........................................................................................................... 566 
Table 15: Correlation between gum bleeding and the five periodontopathogens ............ 577 
Table 16: Correlation between gum pain and the five periodontopathogens ................... 588 
Table 17: Correlation between alcohol consumption and the presence of suspected 
periodontopathogens ............................................................................................................ 599 
Table 18: Correlation between smoking and the presence of suspected 
Periodontopathogens .............................................................................................................. 60 
Table 19: Correlation between clinical signs of gingival inflammation and the presence of 
the five periodontopathogens .............................................................................................. 611 
Table 20: Correlation between the presence of the five periodontopathogens and 
pregnancy outcomes ............................................................................................................. 622 
Table 21: Descriptive statistics of IL-10 and IL-6 results ................................................... 70 
Table 22: Association between maternal medical history and  IL-10 and IL-6 ............... 722 
Table 23: Association between maternal smoking, alcohol consumption and oral health 
care and  IL-10 and IL-6 ...................................................................................................... 733 
Table 24: Association between periodontopathogens and IL-10 and IL-6....................... 744 
Table 25: Association between paired combinations  of periodontopathogens and IL-10 
and IL-6................................................................................................................................. 755 
Table 26: Association between combinations  of three, four, five periodontopathogens 
and IL-10 and IL-6 results ................................................................................................... 766 
Table 27a: Association between pregnancy outcomes and IL-10 and IL-6 results ......... 766 
Table 27b: Correlation between cytokines ratios (IL-6M/ IL-10M and IL-6M/ IL-10M) 
with the 5 periodontopathogens, gingival inflammation and PLBW…..………………..77 
Table 28: Association between IgG against periodontopathogens and maternal history 877 
Table 29: Association between IgM against periodontopathogens and maternal history888 
Table 30: Spearman rank correlation association between cytokins (IL-6 and IL-10) and 
IgG and IgM against periodontopathogens ........................................................................ 899 
Table  31 Principle findings of the study………………………………………………..94 
Table 32: Multivariate analysis of risk factors associated with PLBW ............................ 966 
 
 
 
 
 
 xi
LIST OF FIGURES 
 
Figure 1: PCR amplification of P. gingivalis  using Species-specific primers..………...48 
 
Figure 2: PCR amplification of T. denticola using Species-specific primers …………...48 
 
Figure 3: PCR amplification of P. intermedia using Species-specific primers…………..49 
 
Figure 4: PCR amplification of A. actinomycetemcomitans using Species-specific 
primers…………………………………………………………………………….……...49 
 
Figure 5: PCR amplification of F. nucleatum using Species-specific primers…………..50 
 
 
 
 
 xii
LIST OF ABREVIATIONS USED IN THIS STUDY 
 
+C: Positive control 
-C= Negative control 
Aa: Aggregatibacter actinomycetemcomitans 
Aa-IgG: IgG against Aggregatibacter actinomycetemcomitans 
Aa-IgM: IgM against Aggregatibacter actinomycetemcomitans 
Ag: Antigen 
ANUG: Acute Necrotizing Ulcerative Gingivitis  
ATCC: America Type Culture collection 
CIPD: Chronic Inflammatory Periodontal Disease  
DNA: Deoxyribonucleic Acid 
dNTP: Deoxynucleotide-Triphosphate 
EDTA: Ethylendiaminetetraacetic acid 
EIA: enzyme immunoassay  
ELISA: Enzyme-linked Immunosorbent Assay 
FCB: Foetal Cord Blood 
FIRS: Fetal Inflammatory Response Syndrome 
Fn: Fusobacterium nucleatum 
Fn-IgG: IgG against Fusobacterium nucleatum 
Fn-IgM: IgM against Fusobacterium nucleatum 
GCF: Gingival Crevicular Fluid 
IgG:  Immunoglobulin G 
 
 
 
 
 xiii
IgM:  Immunoglobulin M 
IL: Interleukin   
JAMA: Judicial Affairs, American Medical Association. 
LBW: Low Birth Weight  
LPS: Lipopolysaccharide 
NIH: National Institutes of Health  
NT: Normal Term 
MB: Maternal blood 
O.D: Optical Density 
PA: Protein A 
PBMC: Peripheral Blood Mononuclear Cells  
PBS: Phosphate buffered Saline 
PBS-T: Phosphate buffered Saline- Tween 
PCR: Polymerase Chain Reaction  
Pg:  Porphyromonas gingivalis 
Pg-IgG: IgG against Porphyromonas gingivalis 
Pg-IgM: IgM against Porphyromonas gingivalis 
Pi:  Prevotella intermedia  
Pi-IgG: IgG against Prevotella intermedia 
Pi-IgM: IgM against Prevotella intermedia 
PG:  prostaglandin 
PLBW: Preterm Delivery of Low Birth Weight infants 
 
 
 
 
 
 xiv
PT: Preterm 
PTB: Preterm birth 
PTD: Preterm Delivery 
PTL: Preterm Labor 
SDS: sodium dodecylsulphate detergent  
SIRS: Systemic Inflammatory Response Syndrome 
SPSS: Statistical Package for the Social Sciences 
STD: sexually transmitted disease 
TBE: Tris Borate EDTA 
Td: Treponema denticola 
Td-IgG: IgG against Treponema denticola 
Td-IgM: IgM against Treponema denticola 
Th: T-helper 
TNF: Tumor Necrosis Factor 
TSA: Trypticase Soy Agar 
UV: Ultra Violet   
WC: Wilkins Chalgren anaerobic broth medium  
 
 
 
 
 
 
 1
CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1. BACKGROUND: 
 
Clinical research has in the past largely excluded women. Diseases that affect them 
disproportionately were less likely to be studied (Angel, 1993; Schiebinger, 2003) and it is 
only during the last decade that research has focused on issues relating to women’s health. 
In the US for example, it is only since 1990 when the office of research on women’s health 
within the office of the Director at the National Institutes of Health (NIH), reviewed 
inequities in biomedical research, treatment and diagnosis of diseases affecting women 
(Schiebinger, 2003). More research is needed, particularly in pregnant women, of whom 
three-quarters require drug therapy during pregnancy and use prescription medication for 
chronic conditions such as diabetes or depression (Schiebinger, 2003). 
 
It has been suggested that oral infection can act as the site of origin for dissemination of 
periodontopathogens and their toxins as well as induce inflammatory mechanisms to distant 
body sites, thus linking periodontal diseases to pre-term delivery of low birth weight 
(PLBW) infants (Offenbacher et al., 1996, 1998a,b, 2001; Dasanayake, 1998; Champagne et 
al. 2000; Williams et al. 2000; Louro et al. 2001; Jeffcoat et al., 2001; Mitchell-Lewis et al., 
2001; Lopez et al., 2002; McGaw, 2002; Amar and Han, 2003; Han et al., 2004; Russel and 
Dasanayake, 2006; Lin et al., 2007).  
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Although women take better care of their teeth than men, three-quarters of periodontal office 
visits are made by women (Zakrzewska, 1996; University of Maryland Medical Center, 
2008). Female hormones during puberty, menses, pregnancy, contraceptive use and 
menopause have been suggested to play an important role in periodontal disease infection 
(Steinberg, 2000; Sorry, 2000; Blagojevic et al, 2002, Krejci and Bissada, 2002, Yalcin et 
al., 2002; Mascarenhas et al., 2003; University of Maryland Medical Center, 2008). 
Periodontal disease is an infection of the tissues surrounding and supporting the teeth 
(Marsh and Martin, 1992). The increases of estrogen and progesterone concentration in 
plasma stimulate bacterial growth and are associated with periodontal disease progression 
(Zachariasen, 1991, 1993; Soory, 2000; Tilakarantne et al., 2000; Bueltmann and Stillman, 
2002; University of Maryland Medical Center, 2008). 
 
1.2. PRE-TERM DELIVERY AND LOW BIRTH WEIGHT INFANTS 
 
Preterm birth is defined as birth before 37 weeks of gestation (Offenbacher, 1996; 
Davenport, 1998; Steer, 2005). Several organ systems in the normal human foetus mature 
between 34 and 37 weeks, and adequate maturity of the foetus is reached at the end of that 
period (Steer, 2005). Low birth weight infants are those who weigh less than 2500 gram. 
Less than 32 weeks of gestation and less than 1500g are defined as very premature and 
extremely low birth weight respectively (World Health Organization, 1950; Truth and 
consequences, 2009). One-third of low birth weight infants are due to preterm delivery, 
however, infants may be underweight for reasons other than preterm delivery (World Health 
Organization, 2009). 
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PLBW is increasing extensively and becoming an important problem in both developing and 
developed countries (McGaw, 2002; Vogel et al., 2005). More than 20 million infants in the 
world (15.5 % o all births) are born with low birth weight. Ninety-five % of them are in 
developing countries (United Nations Children’s Fund and World Health Organization, 
2004). The rate of low birth weight (LBW) in developing countries is more than double 
(16.5 %) that in developed countries (7 %) and in Sub-Saharan Africa, the rate is around 15 
%. In the United States of America in 1993, the rate of low birth weight among blacks was 
13.3 %, 6.0 % among white and 4.9 % among Chinese (Hack and Merkatz, 1995). In 
Denmark it has escalated from 5.6 % in 1994 to 6.9 % in 2003, in Canada from 6.4 % in 
1981 to 7.1 % in 1996 (Vogel et al., 2005). Generally, the rate of preterm birth in Europe 
and many other developed countries varies from 5 to 9 % (Goldenberg et al, 2008).  
 
It is known that PLBW infants are exposed to serious health problems, including, 
neurodevelopmental disturbances, ear infections, respiratory infections, asthma and death 
(Shapiro et al., 1980, Cooke, 2006; Hack and Costello, 2007). Ten % of neonatal mortality 
world-wide is caused by prematurity (Child Health Research Project Special Report, 1999). 
In the US, 25 % of neonatal mortality is due to prematurity (Mathew and MacDorman, 
2006). Preterm delivery is a significant cost factor in healthcare resulting in a considerable 
cost of long-term care for children with disabilities. A study in US showed a neonatal cost of 
$ 224, 400 for a newborn at 500-700 g, while only $1,000 for a newborn at over 3,000 g 
(Gilbert et al., 2003). 
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Different factors have been linked with a higher risk of preterm delivery: Low socio-
economic standards, educational level, single motherhood, age at the upper and lower end (> 
35 or < 18 years of age), multiple pregnancies (twins, triplets etc…), smoking and 
alcoholism during pregnancy, maternal medical conditions such as high blood pressure, 
maternal diabetes, and heart disease (Shiono et al., 1995; Gardner et al., 1995; Martius et 
al., 1998; Goldenberg et al., 1998, Parazzini et al., 2003; Rosenberg et al., 2005; 
Goldenberg et al., 2008). Infections play a major role in the cause of PLBW (Goldenberg et 
al., 2000). Researchers showed that between 18 and 50 % of all pre-term deliveries are 
associated with periodontal disease and this appeared to increase more than 7 times after 
adjusting for smoking, vaginosis treatment history, marital status, previous preterm, race and 
age (Offenbacher et al. 1998a, 2001; Romero et al. 1998; McGaw, 2002). In most of the 
cases of PLBW, the aetiology is unknown and no method to prevent pre-term labour has 
proven effective (Schellenber, 2003).  
 
1.3. EXPLORING THE ROLE OF PERIODONTAL INFECTIONS 
 
1.3.1. Background 
 
Periodontium or periodontal tissues, are tissues that surround, support and maintain the teeth 
in the maxillary and mandibular bones. The periodontium is formed by the gingiva, the 
alveolar bone, the periodontal ligament and the cementum (Manson and Eley, 2000).  Like 
other tissues, the periodontal tissues are subject to a number of diseases. The disease process 
may be limited to the gingiva or involve the deeper periodontal structures (Manson, 1970). 
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The 2 forms of periodontal disease are gingivitis and periodontitis. In gingivitis, the gingiva 
are red, swollen and can bleed easily resulting in false pocket formation. Gingivitis can be 
treated by improving oral hygiene practice. If it is not treated, toxins from bacteria can 
penetrate deep tissues of the periodontium and destroy the periodontal membrane and the 
alveolar bone causing periodontitis.  A true periodontal pocket is formed, caused by the 
migration of the junctional epithelial tissue at the base of the gingiva down the root of the 
tooth (Levison, 1997). At the late stage of periodontitis, gingiva and alveolar bone can be 
seriously damaged, resulting in tooth loss (Marsh and Martin, 1992, Bagg et al., 1999).  
 
Most periodontal diseases are associated with the presence or overgrowth of anaerobic 
bacteria either alone or in association. Using statistical analysis, Socransky et al., (1998) 
clustered frequently occurring bacterial species into complexes which were colour-coded in 
order to facilitate discussion (Table 1). The red complex was found to be most closely 
associated with pocket depth and bleeding on probing, while the orange complex related to 
pocket depth but less frequently with the other clinical parameters used in the diagnosis of 
periodontal disease. 
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Table 1: Bacterial clusters described by Socransky et al (1998). 
Complex Bacterial cluster 
Red Treponema denticola, Porphyromonas gingivalis, Tannerella 
forsythia 
Orange Fusobacterium nucleatum, Prevotella intermedia, Prevotella 
nigrescens, Micromonas (Peptostreptococcus) micros, Eubacterium 
nodatum, Campylobacter rectus, Campylobacter showae, 
Streptococcus constellatus, Campylobacter gracilis) 
Yellow Streptococcus sanguis, Streptococcus oralis, Streptococcus mitis, 
Streptococcus gordonii, Streptococcus intermedius 
Green Capnocytophaga, Campylobacter concisus, Eikenella corrodens, 
Aggregatibacter actinomycetemcomitans (serotype a) 
Purple Veillonella parvula, Actinomyces odontolyticus, 
Aggregatibacter actinomycetemcomitans (serotype b), Selenomonas 
noxia, Actinomyces naesludii 
 
 
Among the suspected periodontopathogens associated with PLBW are the orange and red 
complexes which were found in 18% of full-term and 100% of preterm delivery cases 
(Offenbacher et al. 1996; Dörtbudak et al., 2005). Microbiology and immunology studies 
reveal that high maternal immunoglobulin G (IgG) levels against periodontopathogens and 
high counts of periodontopathic bacteria were found in mothers who delivered PLBW (Hill, 
1998; Offenbacher et al. 1996; Dasanayake et al. 2001, 2003; Madianos et al., 2001; 
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Dörtbudak et al., 2005; Lin et al., 2007). However, Madianos et al., (2001) and Lin et al, 
2007 reported that lack of maternal IgM antibody to the red complex was associated with 
preterm delivery and that maternal IgG to suspected periodontopathogens was associated 
with a decrease of PLBW frequency.  
 
No difference was found in the levels of dental plaque periodontopathogens or serum 
antibody between mothers with PLBW infants and the control group in a study by Jarjoura 
et al., (2005). In a recent meta-analysis of randomized controlled trials (RCTs) of pregnant 
women with periodontal disease, after pooling the results of 10 published eligible RCTs, the 
researchers found that treatment for periodontal disease did not reduce the rate of preterm 
birth (PTB) (Michalowicz et al., 2006; Offenbacher et al., 2009; Jeffcoat, 2010; Niederman, 
2010). 
 
 In contrast, greater attachment loss was associated with PLBW. Another study with a small 
interventional trial found that effective periodontal treatment in the second trimester of 
pregnancy had 3.8 times reduction in the rate of PLBW compared to the control group with 
delayed periodontal treatment (Offenbacher et al., 2006). Lin et al (2007) suggested that 
microbiological and serologic markers could be used in the regular gynecological checkup 
during pregnancy to prevent PLBW.  
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1.3.2. The host immunological response in periodontal disease 
 
The inflammatory defense mechanisms in periodontal disease are defined as non-specific, 
because the inflammatory stimulus gives rise to similar reactions. The response is quick and 
designed to stop the spread of infection, but it usually requires an immune response targeted 
at the specific periodontopathogens present (David et al., 1992). Evidence of the activity of 
the immune mechanisms in periodontitis include the presence of lymphocytes and plasma 
cells in the gingiva, circulating antibody to plaque antigens and the correlation of antibody 
levels with disease severity (David et al., 1992). 
 
Antigens are carried to the local lymph nodes by macrophages and presented to lymphocytes 
which circulate them through the nodes and tissues (David et al., 1992). The lymphocytes 
which recognize each individual antigen are activated and secrete antibody under the control 
of helper and suppressor T lymphocytes. B and T lymphocytes have been implicated as the 
primary sources of bone resorption lesions in periodontal disease (Kawai et al., 2006).  The 
predominant antibody is IgG (75 %) with a small amount of IgM (7 %). After passing the 
gingival inflammatory exudates, antibodies pass into the gingival crevice in the crevicular 
fluid (David et al., 1992).  
 
Due to a continual presence of plaque bacteria in periodontal disease, there is no primary 
response followed by a larger secondary response like in acute infections. In contrast, there 
is a prolonged secondary response of constant antibody secretion which will persist at a 
lower level even after effective treatment (David et al., 1992). Although most of the 
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antibody in crevicular fluid is derived from the blood, around 15 % of the IgG is produced 
locally by plasma cells in the tissues.  
 
A high rate of circulating antibodies against different oral bacterial species and many of 
their products have been detected in adult periodontitis, such as P. gingivalis and A. 
actinomycetemcomitans in aggressive periodontitis and Prevotella intermedia in Acute 
Necrotizing Ulcerative Gingivitis (ANUG). Although antibodies have not been shown to be 
protective in humans, polyclonal activators stimulate B lymphocytes and plasma cells to 
secrete important cytokines, including interleukin-1 (IL-1) and tumour necrosis factor (TNF) 
(David et al., 1992). Cytokines play different roles in periodontal disease, especially in 
periodontitis, including coordination of tissue turn-over, immunological and inflammatory 
processes.  
 
Cell-mediated reactions play a role in fighting against persistent antigens which are resistant 
to degradation, intracellular pathogens and tumour cells. Few cell-mediated reactions may 
occur in periodontal disease and may be more important during childhood gingivitis than in 
adult periodontitis (David et al., 1992). Seymour et al., (1996) demonstrated the role of cell-
mediated mechanisms in the control of periodontal destruction and suggested that cytokine 
therapy for the treatment of periodontal disease may become a best option. 
 
 
 
 
 10
1.3.3. Role of cytokines in PLBW and their proposed mechanism of action: 
 
IL-1 ß and TNF- α have been reported to regulate trophoblastic cell apoptosis (Yui et al., 
1994). IL-1β detected in second trimester amniotic fluid has been shown to exhibit an 
increase in the onset of labour (Romero et al. 1989, Opsjøn et al., 1993). Konopka et al., 
(2003), found that women with PLBW had a significantly higher level of prostaglandin E2 
(PGE2) and IL-1 ß concentrations in gingival crevicular fluid (GCF). The level of TNF-α 
was significantly elevated in the serum of mice with foetal growth restriction compared to 
levels in mice with normal foetuses (Lin et al., 2003). Parent (1990), reported that placenta 
necrosis and foetal resorption could be induced in rats by the injection of recombinant 
human IL-1 β. Cytokines stimulate PGE2 by the human placenta and chorioamnion (Romero 
et al. 1988b, Gibbs et al. 1992, Kent et al., 1993) and the role of prostaglandin in regulating 
the normal physiology of pregnancy has been well documented (Offenbacher et al., 1998). 
 
The biological mechanism by which periodontal disease may trigger PLBW has not been 
clearly established (Bueltmann, 2002), but an understanding of the response of the mother’s 
immune system to the infection may explain the mechanism postulated by Offenbacher et 
al., (1996, 1998a), Williams et al. (2000) and Gibbs et al, (2001) which suggest that the 
infection may activate the liberation of inflammatory mediators, growth factors and 
cytokines which may provoke PLBW.  High levels of inflammatory cytokines (IL - 1, IL - 6, 
and TNF - α) have been found in the amniotic fluid of patients in preterm labour (Gibbs et 
al., 1992; Offenbacher et al., 1996; Dörtbudak et al., 2005). Hillier et al. (1993) found that 
infection related to preterm labour before 34 weeks was associated with increased levels of 
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IL-1, IL-6 and TNF; they proposed that infection is one cause of preterm delivery operating 
through a mechanism involving the induction of cytokine production. Previous studies 
reported that mitogen-stimulation of maternal peripheral blood mononuclear cells in women 
undergoing preterm delivery elicited higher production of Th1 cytokines and decreased 
production of the Th2 cytokines (Zhang et al., 2000; Raghupathy et al., 2001; Shokshi et al., 
2002; Makhseed et al., 2003). Gomez et al.(1997) reported that while the pathopysiology of 
preterm delivery is not yet well understood, it is proposed that many of the pathological 
effects observed in preterm deliveries are mediated by endogenous host molecules such as 
cytokines.  
 
Different mechanisms have been postulated by Offenbacher et al. (1998a), which can 
explain biological bacterially induced activation of cell-mediated immunity, leading to the 
production of cytokines including: 
1. Translocation of periodontal pathogens such as F. nucleatum and C. rectus to the 
fetoplacental unit resulting in the production of IgM (which cannot pass the placenta barrier) 
obtained from foetal cord serum samples (Offenbacher et al. 1999). Transient bacteremia 
caused by periodontal infection may facilitate bacterial transmission from the oral cavity to 
the uterus (Han et al., 2004). 
2. Translocated bacterial endotoxins such as lipopolysaccharide (LPS) are known to 
stimulate production of prostaglandins by the placenta and chorioamnion with higher 
concentrations of LPS measured in the amniotic fluid of PLBW infants (Romero et al., 
1987, 1988; Offenbacher et al. 1996, Gibbs et al. 1992). Even when no bacteria are 
identified in 18% to 49% of histologically inflamed chorioamniotic membranes, the role of 
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periodontal infection as a possible risk factor for PLWB is still maintained (Mueller-
Heubach et al. 1990).  
 3. High concentrations of cytokines produced at sites of chronic periodontitis and found at 
higher levels in the plasma of patients with periodontitis may cross human foetal membranes 
and thus contribute to PLBW (Romero et al. 1993; Page, 1991, 1998).  
 
1.4. HYPOTHESIS: 
 
It is only recently that research has focused on maternal health and the possible threat to 
their infants, thus the question about the host response being harmful or beneficial in 
periodontal disease has not been resolved. More sex-specific research to determine strategies 
to prevent and treat diseases that have particular impact on women are needed (Krejci and 
Bissade, 2002; Tauman et al., 2005; Keith et al., 2007, Ishikawa, 2007). Although isolated 
studies have established some association of changes in microbiota in different stages of the 
female life-cycle, there are many unanswered questions relating to the effect oral disease can 
have on the unborn child. Few studies have been done relating the association between 
periodontal disease and PLBW focusing on oral microbial infection and their stimulation of 
antibody responses (Lin et al., 2007) and there is a need for further studies with larger 
sample populations to establish this association (Jarjoura et al., 2005; Qureshi et al., 2005; 
Yeo et al., 2005; Offenbacher et al., 2006; Lin et al., 2007). To our knowledge, no studies 
have been done in Sub-Saharan Africa relating the association of periodontal infections 
through their inflammatory cytokines with PLBW. This study is designed to use a molecular 
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approach to test the hypothesis that periodontal pathogens may be associated with preterm 
birth. 
 
1.5. OBJECTIVES: 
 
The objective of this study was: 
- To detect specific suspected periodontopathogens in maternal gingival crevicular 
fluid using PCR and examine their dissemination following the induction of maternal 
immune (IgG, IgM) and inflammatory responses (IL-6, IL-10) by examining serum 
samples from mothers and foetal cords in PLBW and normal birth and relating their 
associations to PLBW. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1. PATIENT SELECTION 
 
This study requested the participation of 100 cases of PLBW and 100 controls of normal 
term (NT) obtained from all sequential deliveries which occurred from May to December 
2008 in the department of obstetrics and gynecology of the teaching hospital of Butare in 
Rwanda. Medical records were used and mothers were asked to complete a questionnaire 
within 48 hours after delivery in order to identify factors such as their medical history, 
factors predisposing for periodontal disease, previous preterm delivery, and oral hygiene 
habits (see appendix 2A) which might pose a health risk to them and their infants. The stage 
of gestation was checked by recording the last date of menstruation of the patient or by 
ultrasound. Informed consent was obtained from the participants in verbal and written form 
as defined by the Medical Research Council, 2001 (see appendix 2B). They were informed 
of the purpose of the study, potential harms, injuries, discomforts or inconveniences which 
may be experienced as well as potential benefits (see appendix 2C). They were required to 
sign the form if they agreed to participate in the study and were assured of confidentiality of 
any disclosures. The study was ethically approved by the Senate Research Committee of the 
University of the Western Cape.  
 
 
 
 
 
 
 
 
 15
2.2. CLINICAL EXAMINATION AND SAMPLE COLLECTION 
 
A dentist, a medical doctor, nurses and lab technicians assisted with the clinical examination 
and sample collection.  
 
2.2.1. Oral examination and gingival crevicular fluid (GCF) sample collection 
 
Samples were collected within 48 hours of delivery. Prior to sampling, the patients were 
examined for signs of gingival inflammation and/or bleeding which might be attributed to 
lack of oral health care. No attempt was made for an accurate diagnosis of gingivitis or 
periodontitis using clinical indices or radiographs and instead, gingival inflammation was 
recorded by the dichotomous score of “presence” or “absence”. All clinical examinations 
and sample collections were done by the same clinician. Gingival crevicular fluid (GCF) 
was collected from four teeth: 
- Maxillary right first molar (16) 
- Maxillary left first molar (26) 
- Mandibular left first molar (36) 
- Mandibular right first molar (46), by inserting sterile filter paper strips (PropFlow, Inc., 
Amityville, NY) into the base of the pocket for one minute per tooth (Goodson, 2003). Care 
was taken to prevent saliva or blood contamination during collection. Each paper strip was 
placed into 50 µl phosphate buffered saline sampling buffer in an Eppendorf tube with 
added 0.05 % tween-20 (PBS-T) and stored at -800 C (Garmonal et al., 2000). Samples were 
transported on dry ice to South Africa and stored at -800 C until analysis.  
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2.2.2. Blood sample collection 
 
Ten ml of foetal cord blood samples were collected at delivery and 10 ml of maternal blood 
samples were collected within 48 hours after delivery (Madianos et al., 2001), into untreated 
blood collection tubes (MediPlus, Cat. No: VP4011). The blood samples were stored  at + 40 
C overnight and centrifuged at 3.000 rpm for 10 minutes, then serum collected and stored in 
aliquots at -800C (Papapanou et al., 2000).  
 
2.3. EVALUATION OF IL-6 AND IL-10 LEVELS USING ELISA 
 
Maternal serum samples and foetal cord serum samples were used for the evaluation of IL-6 
and IL-10 levels using ELISA kits (eBioscience). The preparation of ELISA reagents are 
explained in appendix F. 
 
2.3.1. ELISA test protocol 
 
Coat corning costar 9018, 96 well ELISA plates were coated with 50 µl/well of capture 
antibody in coating Buffer. Plates were sealed with a film sealing cycler (Lasec SA Pty Ltd), 
incubated overnight at 40 C, then aspirated and washed 5 times with 250 µl/well wash 
buffer. Wells were blocked with 100 µl/well of 1x Assay Diluents and incubated at room 
temperature for 1 hour. Plates were washed as described previously. Fifty µl/well of the 
standard (Recombinant human IL-6 or IL-10: 1 ug/ml) were added to the top wells and two-
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fold serial dilutions of the top standards were performed to make the standard curve. For the 
IL-6 standards, the following 2-fold serial dilutions were made: 200 pg/ml, 100 pg/ml, 50 
pg/ml, 25 pg/ml, 12.5 pg/ml, 6.25 pg/ml, 3.12 pg/ml and 0 pg/ml and for Il-10: 500 pg/ml, 
250 pg/ml, 125 pg/ml, 65.5 pg/ml, 31.25 pg/ml, 15.62 pg/ml, 7.81 pg/ml and 0 pg/ml. Fifty 
µl/well of the samples was added to the appropriate wells (see Table 2). Plates were sealed 
and incubated at room temperature for 2 hours (or overnight at 4oC for maximal sensitivity).  
  
Table 2. Illustration of ELISA standards and sample disposition. 
  1 2 3 4 5 6 7 8 9 10 11 12 
A Std1 Std1 1 1 10 10 18 18 26 26 34 34 
B Std2 Std2 2 2 11 11 19 19 27 27 35 35 
C Std3 Std3 3 3 12 12 20 20 28 28 36 36 
D Std4 Std4 4 4 13 13 21 21 29 29 37 37 
E Std5 Std5 5 5 14 14 22 22 30 30 38 38 
F Std6 Std6 6 6 15 15 23 23 31 31 39 39 
G Std7 Std7 8 8 16 16 24 24 32 32 40 40 
H Std0 Std0 9 9 17 17 25 25 33 33 41 41 
Std: Standards 
 
Plates were aspirated and washed as described previously. Fifty µl/well of detection 
antibody diluted in 1x assay diluent was added. Plates were sealed and incubated at room 
temperature for 1 hour. Another step of aspiration and washing was performed as described 
previously. Fifty µl/well of avidin-HRP diluted in 1x assay diluent was added. Plates were 
sealed and incubated at room temperature for 30 seconds. A last step of aspiration and 
washing was performed. In this washing step, wells were soaked in wash buffer for 1 to 2 
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minutes. This was repeated for a total of 7 washes. Fifty µl/well of substrate solution was 
added to each well. Plates were incubated at room temperature for 15 minutes. Fifty µl/well 
of stop solution 2 normal sulfuric acid (2N H2SO4) was added to each well. Readings of the 
optical density (O.D) were made at 450 nm using a microtiter plate reader (Thermo Electron 
corporation, Multiskan Ex).  
 
2.3.2. Calculation of results 
 
A standard curve was used to determine the amount of IL-6 or IL-10 in the samples. 
Standard curves were generated by plotting the average O.D (450nm) obtained for the 
standard concentration on the horizontal axis (X) versus the corresponding IL-6 or IL-10 
concentration (pg/ml) on the vertical axis (Y). The main O.D. value for each standard and 
sample were calculated and all O.D. values were subtracted by the value of the zero-
standard before interpretation of results. The standard curve was constructed using Excel.  
 
2.4. ESTIMATION OF MATERNAL SERUM AND FOETAL CORD 
IMMUNOGLOBULINS  
 
2.4.1. Bacterial strains used and preparation of bacterial antigens 
 
In the development of this assay, the following strains were used as antigens: 
Porphyromonas gingivalis strain America Type Culture collection ATCC 33277, 
Treponema denticola strain ATCC 33521, Prevotella intermedia strain ATCC 25611, 
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Fusobacterium nucleatum strain NTCC 10562, and Aggregatibacter  
actinomycetemcomitans strain ATCC 33396. 
 
Isolation of the above species was done on Trypticase Soy Agar-CY/Dithio (TSA-CT) (See 
preparation appendix E) in an atmosphere of 80 % N2, 10 %CO2 and 10%H2 at 370 C for 5 
days. The cultures were transferred in Peptone Yeast Sugars (see appendix E), where they 
were further grown for 2 to 3 days under the conditions mentioned above and then 
subcultured onto TSA-CT plates. The purity of the culture was confirmed by colony 
morphology and Gram stain. The broth was then centrifugated at 5,500 X g at room 
temperature for 15 min and the bacterial pellet washed 3 times in (PBS). After washing, the 
bacteria were sonicated for 20 secondes to disperse the cells. The density of the bacterial 
suspension in the antigen buffer (PBS) was adjusted to give an absorbance of 0.15 at 580 nm 
and stored in 20 µl aliquots at -80o C until needed. 
 
2.4.2. ELISA ASSAY 
 
A 1/100 dilution in PBS of the 5 different antigens was made and 50 µl/well used to coat the 
plates. Two columns were allocated to each antigen for coating and the last two columns 
were allocated to the protein A from Staphylococcus aureus as a conjugate binding substrate 
(See Table 3). Staphylococcal protein A binds with high and moderate affinity to human IgG 
and IgM respectively (Sasso et al, 1989). This was used as a baseline for calculation of IgG 
and IgM levels. Protein A was diluted in PBS to a concentration of 0.15 μg/ml and 50 
µl/well loaded in the two last columns for coating. The plates were sealed and incubated 
 
 
 
 
 20
overnight at 40 C. Plates were aspirated and washed 5 times with 250 µl/well wash buffer. 
The nonspecific binding was blocked by 200 µl/well of 2 % bovine albumin in PBS at room 
temperature for 1 hour. Plates were aspirated and washed as described previously. Fifty 
µl/well of samples diluted 1/500 for IgG and 1/100 for IgM in (2 % bovine albumin in PBS) 
were loaded perpendicularly to the antigen. The first row was allocated to the positive 
control, from the second to the sixth were allocated to samples from different patients and 
the last row was allocated for the negative control in which we put only 50 µl/well of the 
blocking solution (2 % bovine albumin in PBS). Each sample was loaded in duplicate for the 
different antigens (See Table 3).  
 
Table 3. Illustration of ELISA for IgG and IgM’s  
   1 2 3 4 5 6 7 8 9 10 11 12 
→+C A Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→S1 B Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→S2 C Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→S3 D Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→S4 E Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→S5 F Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→S6 G Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
→-C H Pi-Ag Pi-Ag Pg-Ag Pg-Ag Fn-Ag Fn-Ag Aa-Ag Aa-Ag Td-Ag Td-Ag PA-Ag PA-Ag 
Ag = Antigen,  Pi = Prevotella intermedia, Pg = Porphyromonas gingivalis, Fn =Fusobacterium nucleatum, Aa = Aggregatibacter 
actinomycetemcomitans, Td  = Treponema denticola, PA = Protein A, +C = Positive control, -C= Negative control and Sn = Sample 
number 
 
The plates were sealed and incubated at room temperature for one hour. Plates were 
aspirated and washed as described previously. Peroxidase conjugated goat anti-human (IgG 
or IgM) diluted 1/30,000 in the blocking solution was used as a second antibody. Fifty µl of 
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the above solution was loaded in each well and the plates were sealed and incubated at room 
temperature for one hour. Plates were aspirated and washed as described previously but this 
time for a total of 7 washes. Fifty µl/well of substrate solution was added to each well. 
Plates were incubated at room temperature for 10 minutes. Fifty µl/well of stop solution (2N 
H2SO4) was added to each well and readings of the optical density (O.D) were made at 450 
nm using a microtiter plate reader (Thermo Electron corporation, Multiskan Ex). The main 
O.D. value for each sample was calculated and all O.D. values were subtracted by the value 
of the zero-standard (Negative control) before interpretation of results. The IgG or IgM 
levels were expressed in percentage compared to O.Ds of protein A (100 %). 
 
2.5. 16S rRNA GENE DETECTION BY PCR 
 
Polymerase Chain Reaction (PCR) was used for the detection of the presence of the 5 target 
bacteria of this study.  
 
2.5.1. Sample preparation 
 
Samples from the freezer were thawed by incubation at 37o C for 10 min, then centrifuged 
(10.000 X g) for 15 minutes at 4o C. The supernatents of the 4 tubes from each patient were 
pooled to yield a single sample representing all four quadrants of the mouth for each patient 
(Kim et al, 2007). Samples were vortexed for 30 seconds and centrifuged at 2500X g for 2 
minutes. The supernatent was removed and the pellet resuspended in 100 µl of distilled 
water. Another step of vortexing and centrifugation was done and the pellet was 
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resuspended in 500 µl of distilled water. The suspension was heated at 940 C for 10 min and 
the vials immediately chilled on ice for 5 min. 
 
2.5.2. Preparation of reference DNA 
 
Bacterial cultures were centrifuged at 4000 rpm for 10 minutes at 40 C, washed in Tris  
Hydroxymethyl Methylamine (TES see appendix D) buffer, resuspended in 20 ml TES and 
stored at -80o C. Cells were lysed by the addition of 1 mg/ml lysozyme and incubated for 10 
minutes at 37o C or until changes in colour or viscosity were seen. Lipid molecules were 
removed by the addition of sodium dodecylsulphate detergent (SDS see appendix D) to a 
final concentration of 1 %, followed by another incubation at 37o C for 10 minutes. 
Proteinase K (1 mg/ml, dissolved in 0.5 M Tris-HCl pH 7.2) was added and DNA incubated 
at 37o C for 30 minutes. Proteinase K was added to facilitate the breakdown of protein 
molecules and facilitate phenol extraction. Protein was precipitated and extracted with 
phenol/chloroform as follows: a volume of 500 μl of the aqueous solution of DNA was 
added to 250 μl phenol solution and 250 μl chloroform, gently mixed by inversion for 1 
minute, then spun at 4000 rpm for 10 minutes. Because phenol and water are immiscible, the 
protein was extracted into the phenol layer (bottom layer), leaving nucleic acids in the 
aqueous top layer. The aqueous top layer containing nucleic acids was removed. The 
extraction procedure was repeated twice. DNA was precipitated by the addition of 50 μl of 
5M NaCl and 1 ml of 100 % ethanol. After chilling on ice for 3-5 minutes, the tube was 
gently mixed by inversion and spun for 10 minutes at 4o C. If the high molecular weight 
nucleic acids were not precipitated as a white fibrous material, but rather as a colourless, 
gelatinous material, it indicated that protein was still bound to the nucleic acid. The nucleic 
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acid was then treated with 24 ribonuclease (RNase) at 65o C for 10 minutes (10 mg in 1 ml 
TE buffer), followed by another round of proteinase K treatment, phenol/chloroform 
extraction and ethanol precipitation. The pellet was washed in 70% ethanol without 
centrifugation (just poured off without mixing) and resuspended in 500 μl sterile distilled 
water. Fifty μl 5M ammonium acetate (see appendix D) was added, followed by 1 ml cold 
ethanol. The solution was mixed by inversion and left to precipitate at -20o C for 5 minutes. 
The DNA was carefully spooled with a glass rod and washed by dipping in 500 μl 70% 
ethanol, and then in 100 μl TE. The DNA was left overnight at 37o C, if not dissolved 
immediately. If the DNA preparation appeared very dilute, it was concentrated as follows: 
300 μl DNA was mixed with 30 μl 5M NaCl and 750 μl cold ethanol, incubated at -20o C for 
at least an hour, then spun (10000X g) at room temperature for 10 minutes. The supernatent 
was removed and the pellet washed with 70% ethanol, dried under vacuum and resuspended 
in 100 μl TE. This phase was re-extracted with 600 μl TE.  
 
2.5.3. PCR amplification 
  
Chilled samples were centrifuged for 10 seconds at 9000 X g and 5 µl aliquots of the 
supernatents were used in the PCR assay. Twenty-five µl of the DreamtaqTM Green PCR 
Master Mix (2X) (FE K1081, Inqaba biotec), 0.1-1.0 µM of each primer and 18 µl of water 
nuclease were added to the 5 µl of template DNA. Species-specific primers (Inqaba biotec) 
were used to detect the presence of the 5 target organisms in this study. The expected 
product lengths were 404 bp for P. gingivalis, 316 bp for T. denticola, 307 bp for P. 
intermedia, 500 bp for A. actinomycetemcomitans, and 705 bp for F. nucleatum. 
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Confirmation of PCR reaction was achieved by the use of a pair of ubiquitous primers 
product length (602 bp) which matches most bacterial 16S rRNA genes at the same position. 
Nucleotide sequences of selected and modified 16S rDNA primer pairs are listed in Table 4. 
 
Table 4: PCR primer sequences used for detection of our target bacteria 
Target PCR primer pairs (5’-3’)  Source 
Porphyromonas gingivalis: - Forward 
                                             -Reverse 
AGG CAG CTT GCC ATA CTG CG 
   ACT GTT AGC AAC TAC CGA TGT 
Rocas et al., (2001) 
Treponema denticola: - Forward 
                                    - Reverse 
TAA TAC CGA ATG TGC TCA TTT ACA T 
  TCA AAG AAG CAT TCC CTC TTC TTC TTA 
Rocas et al., (2001) 
Prevotella intermedia: - Forward 
                                    - Reverse 
CAA AGA TTC ATC GGT GGA 
GCC GGT CCT TAT TCG AAG 
Kook et al (2005) 
Fusobacterium nucleatum: - Forward 
                                            - Reverse 
ATT GTG GCT AAA AAT TAT AGT T 
ACC CTC ACT TTG AGG ATT ATA G 
Mayanagi et al., (2004) 
Aggregatibacter actinomycetemcomitans: 
                                            - Forward 
                                            -Reverse 
 
GCT AAT ACC GCG TAG AGT CGG 
ATT TCA CAC CTC ACT TAA AGG T 
Avila-campos and Julio (2003) 
Ubiquitous primers: - Forward 
                                 - Reverse 
GAT TAG ATA CCC TGG TAG TCC AC 
   CCC GGG AAC GTA TTC ACC G 
Rocas et al., (2001) 
 
 
Preparation of the PCR cocktail 
 
1. A gentle and brief vortex and centrifugation of the DreamtaqTM Green PCR Master 
Mix(2X) (Inqaba biotec) was done after thawing. The Dream taq DNA polymerase 
was supplied in 2X Dream taq green buffer, dNTPs and 4 mM MgCl2 and a Dream 
Taq green buffer which contained a density reagent and two dyes for monitoring 
electrophoresis progress. 
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2. PCR tubes were placed on ice and components for each 50µl PCR reaction were 
added as follows (See Table 5): 
 
Table 5: Components of the PCR reaction 
 
DreamTaqTM Green PCR Master Mix(2X) 25 µl 
Forward primer 0.1-1.0 µM 
Reverse primer 0.1-1.0 µM 
Template DNA 5 µl 
Water, nuclease-free 18 µl 
Total volume 50 µl 
 
3. A gentle vortex and spin-down of the sample was done. 
4. A volume of 25 µl of mineral oil was added. 
The negative control contained 5 µl of distilled water in place of the sample and the positive 
control consisted of 49 µl from the master mix and 1 µl (100ng) of the reference genomic 
DNA. A brief vortexing of samples was done. PCR amplifications were perfomed as 
follows:  
P. gingivalis (Rocas et al., 2001): an initial denaturation step at 94oC for 2 minutes, followed 
by 36 cycles of a denaturation step at 940C for 30 seconds, a primer annealing step at 600C 
for 1 minute, an extention step at 720C for 2 minutes, and a final step at 720C for 10 minutes. 
T. denticola and ubiquitous primers (Rocas et al., 2001): an initial denaturation step at 950C 
for 2 minutes, followed by 36 cycles of a denaturation step at 950C for 30 seconds, a primer 
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annealing step at 60oC for 1 minute and extention step at 720C for 1 minute, and a final step 
at 720C for 2 minutes. 
P. intermedia (Kook et al 2005): an initial denaturation step at 950C for 2 minutes, followed 
by 36 cycles as one cycle at 94°C  for 30 s (denaturation) followed by 55°C for 1 min 
(annealing) with an elongation of 72°C for 1 minute, and a final step at  720C for 10 
minutes. 
A. actinomycetemcomitans and  F. nucleatum : Same conditions as described previously by 
Rocas et al., 2001.  
 
The PCR products were analyzed by electrophoresis in 1 % agarose gels using Tris-Borate 
EDTA buffer at 90 V. A 100 bp size ladder (O’GeneRuler 100 bp DNA ladder, Fermentas) 
was used as the molecular weight marker. The DNA was stained with ethidium bromide and 
visualized under UV light. 
 
2.6. DATA ANALYSIS 
 
Data were analyzed using SPSS 14.0. All questionnaires, oral examination and laboratory 
data were entered into Excel 2003 and then transferred to Statistical Package for the Social 
Sciences (SPSS) for analysis. Frequencies, means, maximum and minimum were calculated 
using descriptive statistics. The significance of associations was determined using chi-
squared and Fisher’s exact test. Statistical differences between groups, cytokine means and 
antibody levels were determined using Kruskal-wallis test, Mann-Whiteney test and 
spearman rank correlation. A p value of < 0.05 was considered significant. A multivariate 
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analysis using a logistic regression of risk factors associated with PLBW was performed to 
provide an estimate of the odds ratio after adjusting for confounding variables. 
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CHAPTER 3: RISK FACTORS ASSOCIATED WITH PLBW AS 
                      ASSESSED FROM THE QUESTIONNAIRE 
 
3.1. INTRODUCTION 
 
Before sampling and oral examination, mothers were asked to complete a questionnaire in 
order to identify factors which might pose a health risk to them and their infants and also to 
obtain some information regarding different factors which have been linked with a higher 
risk of preterm delivery of low birth weight such as level of education, height of the mother, 
age, smoking, alcoholism during pregnancy, maternal medical conditions such diabetes, 
blood pressure and infection. Not all of the participants responded to all of the questions 
asked, so the results which follow are based on the number of responses to each question, 
and not the total number of participants in the study. The following sections summarize their 
responses to the questionnaire. 
 
3.2. PERSONAL DETAILS OF MOTHERS 
 
Maternal Age 
 
Of the mothers who responded (n = 195), the majority were between the ages of 20-30 years 
(60 %) with a mean age of 28.02 (± 6.089). Generally, age did not appear to influence 
pregnancy outcomes as there was little difference between normal and PLBW except for a 
slight increase in mothers aged between 21-25 and ≥ 36 years of age. The association of 
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PLBW with age was therefore not statistically significant (p =0.557) (Table 6). Ninety-eight 
of the mothers (50.25 %) delivered normal birth, while 97 (49.74 %) delivered PLBW. Five 
mothers failed to respond to this question. 
 
Maternal Weight  
 
One hundred and eighty-eight mothers recorded their weights. The mean (SD) weight was 
61.92 (± 9.569) kg. Of these, PLBW was significantly increased (p = 0.006) in mothers who 
weighed less than 65 kg. Of the 53 mothers weighing > 65 kg, only 28.3 % delivered PLBW 
infants (Table 6). Twelve mothers did not respond to this question. 
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Table 6: Details of Mothers 
 FREQUENCY (%) Normal birth n (%) PLBW n (%) p value 
AGE (years) 
Mean (±SD): 28.02 (± 6.089)  
   0.557 
< 20  
20 – 25  
26 – 30  
31 – 35  
≥ 36 
Total 
17 (8.71) 
60 (30.76) 
58 (29.74) 
37 (18.97) 
23 (11.79) 
195 (100.0) 
 
 
8 (8.2) 
28 (28.6) 
31 (31.6) 
22 (22.4) 
9 (9.2) 
98 (100.0) 
 
 
9 (9.3) 
32 (33.0) 
27 (27.8) 
15 (15.5) 
14 (14.4) 
97 (100.0) 
 
WEIGHT (kg) 
Mean (±SD): 61.92 (± 9.569)   
 0.006 
≤ 50 
51 – 55  
56 – 60  
61 – 65  
> 65  
Total  
16 (8.51) 
35 (18.61) 
45 (23.93) 
39 (20.74) 
53 (28.19) 
188 (100.0)                             
7 (7.01) 
13 (13.3) 
21 (21.4) 
18 (18.4) 
39 (39.8) 
98 (100.0) 
9 (10.0) 
22 (24.4) 
24 (26.7) 
21 (23.3) 
15 (16.6) 
90 (100.0) 
 
HEIGHT (cm) 
Mean (±SD): 158.68 (± 7.598) 
   0.041 
 
≤ 150  
151 – 155  
156 – 160   
161 – 165  
> 165  
Total 
 
30 (16.30) 
41 (22.28) 
43 (23.36) 
40 (21.73) 
30 (16.30) 
184 (100.0) 
 
15 (15.6) 
20 (20.8) 
16 (16.8) 
23 (24.0) 
22 (22.9) 
96 (100) 
 
15 (17.0) 
21 (23.9) 
27 (30.7) 
17 (19.3) 
8 (9.1) 
88 (100.0) 
 
 
LEVEL OF EDUCATION    0.355 
No formal education 
Primary school 
High School 
university 
Total 
18 (9.13) 
121(61.42) 
43 (21.82) 
15 (7.61) 
197 (100.0) 
6 (6.1) 
59 (60.2) 
24 (24.5) 
9 (9.2) 
98 (100.0) 
12 (12.1) 
62 (62.6) 
19 (19.2) 
6 (6.1) 
99 (100.0) 
 
MAIN DIET    0.197 
Bread 
Meat 
Fruit and veg 
Bread and meat 
Bread, fruit and veg 
Meat, Fruit and veg 
Bread, meat, fruit and veg 
Total 
5(2.57) 
26(13.40) 
121(62.37) 
3(1.54) 
3(1.54) 
14(7.21) 
22(11.34) 
194(100.0) 
2 (2.1) 
15 (15.5) 
64 (66.0) 
3 (3.1) 
1 (1.0) 
5 (5.2) 
7 (7.2) 
97 (100.0) 
3 (3.1) 
11 (11.3) 
57 (58.8) 
0 (0.0) 
2 (2.1) 
9 (9.3) 
15 (15.5) 
97 (100.0) 
 
 
Maternal height  
Only 184 mothers recorded their height. The mean (SD) maternal height was 158.68 (± 
7.569) cm. A significant correlation (p = 0.041) was observed between the height of the 
mother and PLBW. Mothers with a height ≤ 160 cm were more likely to deliver PLBW 
while those measuring ≥ 161 cm were more likely to deliver full term and normal weight 
infants (Table 6).  
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Level of Education 
 
One hundred and ninety-seven mothers (98.5 %) responded to this question. The majority 
(61.42 %) of whom had completed their primary school, followed by high school (21.82 %) 
with 9.13 % having had no formal education and 7.61 % having reached university level 
(Table 6). Although the number of PLBW increased slightly in mothers with no formal 
education, no significant association (p = 0.355) could be observed between level of 
education and PLBW. 
 
Diet 
 
Only 6 mothers (3.0 %) did not report on their diet. The majority (62.37 %) of our patients 
reported fruit and vegetables as their main diet, followed by a predominantly meat diet (13.4 
%). There was no significant correlation (p = 0.197) between the diet of the mother and 
PLBW (Table 6). 
3.3. MEDICAL HISTORY OF THE MOTHERS 
 
Diabetes 
 
Three (1.53 %) of the 195 (97.5 %) mothers who responded to this question, reported a 
history of diabetes (Table 7), of which 2 (2.1 %) delivered PLBW and 1 (1.0 %) delivered 
normal birth. No significant difference was observed for pregnancy outcomes between those 
with a history of diabetes and those with no history of diabetes (p = 0.496).  
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Table 7: Medical History of the Mothers  
CHARACTERISTICS FREQUENCY (%) Normal birth n (%) PLBW n (%) p value 
DIABETIC HISTORY    0.496 
Yes 
No 
Total 
3 (1.53) 
192 (99.48) 
195 (100.0) 
1 (1.0) 
97 (99.0) 
98 (100.0) 
2 (2.1) 
95 (97.9) 
97 (100.0) 
 
FAMILY HEART DISEASE HISTORY    0.528 
Yes 
No 
Total 
19 (9.74) 
176 (90.25) 
195 (100.0) 
9 (9.4) 
87 (90.6) 
96 (100.0) 
10 (10.1) 
89 (89.9) 
99 (100.0) 
 
URINARY TRACT INFECTION    0.107 
Yes 
No 
Total 
45 (23.56) 
146 (76.43) 
191 (100.0) 
18 (19.1) 
76 (80.9) 
94 (100.0) 
27 (27.8) 
70 (72.2) 
97 (100.0) 
 
SEXUALLY TRANSMITTED DISEASE    0.080 
Yes 
No 
Total 
28 (14.35) 
167 (85.64) 
195 (100.0) 
10 (10.3) 
87 (89.7) 
97 (100.0) 
18 (18.4) 
80 (81.6) 
98 (100.0) 
 
HISTORY OF ANTIBIOTIC USE    0.079 
Yes 
No 
Total 
58 (29.89) 
136 (70.10) 
194 (100.0) 
24 (24.7) 
73 (75.3) 
97 (100.0) 
34 (35.1) 
63 (64.9) 
97 (100.0) 
 
ALCOHOL USE    0.337 
Never 
Daily 
weekly 
Special occasions 
Total 
98 (52.12)  
24 (12.76) 
29 (15.42) 
37 (19.68) 
188 (100.0) 
46 (48.4) 
10 (10.5) 
18 (18.9) 
21 (22.1) 
95 (100.0) 
52 (55.9) 
14 (15.1) 
11 (11.8) 
16 (17.2) 
93 (100.0) 
 
SMOKERS    0.506 
Yes 
No 
Total 
9 (4.61) 
186 (95.38) 
195 (100.0) 
5 (5.1) 
93 (94.9) 
98 (100.0) 
4 (4.1) 
93 (95.9) 
97 (100.0) 
 
MEDICAL INSURANCE    0.125 
Yes 
No 
Total 
183(93.36) 
13(6.63) 
196(100.0) 
94(95.9) 
4(9.2) 
98(100.0) 
89(90.8) 
9(9.2) 
98(100.0) 
 
GYNECOLOGICAL  CHECK UP    0.059 
Never 
Once a year 
When necessary 
Total 
 
 
71(37.96) 
23(12.29) 
93(49.73) 
187(100.0) 
37 (37.8) 
7 (7.1) 
54 (55.1) 
98 (100.0) 
34 (38.2) 
16 (18.0) 
39 (43.8) 
89 (100.0) 
 
 
 
Heart disease 
 
Of the 195 (97.5 %) mothers who responded to this question, only19 (9.74 %) reported a 
history of heart disease (Table 7). No significant association was observed between presence 
nor absence of heart disease and pregnancy outcomes (p = 0.528). 
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Urinary tract infections 
 
One hundred and ninety-one (95.5 %) mothers responded to this question with the majority 
(76.43 %) reporting no history of recurrent or existing urinary tract infections. Those who 
did, showed a slight increase in PLBW but this was not statistically significant (p=0.107) 
 
Sexually transmitted diseases 
 
Most of the mothers (97.5 %) responded to this question with 28 (14.35 %) reporting a 
history of sexually transmitted diseases (Table 7). Although those who responded positively 
to this question showed an increase in PLBW, the association was not statistically 
significant (p = 0.080). As with the earlier reported histories of diabetes, heart disease and 
urinary tract infections, the sample number of those responding positively may have been 
too small for any significant association to be observed. 
 
Antibiotic therapy 
 
Mothers were asked to report on whether they had received antibiotic therapy during their 
period of gestation. Of the 194 mothers who responded to this question, only 58 (29.89 %) 
reported that they had received antibiotic therapy during their pregnancy (Table 7). An 
increase in PLBW was observed in these mothers, but it was not statistically significantly 
associated (p = 0.079). 
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Alcohol consumption 
 
One hundred and eighty-eight mothers (94.0 %) responded to this question with 98 (52.12 
%) denying any alcohol consumption (table 7). Others reported on daily (12.76 %) and 
weekly (19.68 %) consumption, while others reported alcohol consumption only on special 
occasions (18.5 %). Although a slight increase was observed in PLBW when mothers 
reported daily consumption of alcohol, this association was not statistically significant (p = 
0.337) since an increase in PLBW was also observed when mothers reported never 
consuming any alcohol. 
 
Smoking 
 
Of the 200 patients, only 195 (97.5 %) reported on smoking habits, of which 9 (4.61 %) 
admitted to smoking, while 186 (93.38 %) reported that they had never smoked (Table 7). 
Smoking did not appear to influence pregnancy outcomes (p = 0.506). 
 
Medical insurance and gynecological visits 
 
Although 183/196 (93.36 %) mothers reported having medical insurance which allowed 
them access to medical care (Table 7), 93/187 (49.73 %) reported visiting a gynecologist 
only when necessary, 71 (37.96 %) responded never visiting a gynecologist (Table 7) and 23 
(12.29 %) claimed that they visited a gynecologist once a year. Again a slight increase in 
PLBW in mothers never visiting a gynecologist and those visiting once a year, was not 
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significantly associated (p = 0.059) with pregnancy outcomes, nor was there an association 
with access to medical insurance (p = 0.125). 
 
3.4. HISTORY OF PREVIOUS DELIVERIES 
 
Health condition of children 
 
Data from 131 (65.5 %) mothers was available regarding the health condition of children in 
the family. Healthy children were reported by 124 (94.65 %) mothers, while 7 (5.34 %) 
reported unhealthy children (Table 8). A significant difference (p=0.003) was observed 
between the health condition of the children in the family and PLBW. Only children born 
PLBW were reported to be unhealthy (Table 8). 
 
Table 8: History of Previous Deliveries 
CHARACTERISTICS FREQUENCY (%) Normal birth n (%) PLBW n (%) p value 
CONDITION OF CHILDREN IN THE 
FAMILY 
   0.003 
Healthy 
Not Healthy 
Total 
124 (94.65) 
7 (5.34) 
131 (100.0) 
71 (100.0) 
0 (0.0) 
71 (100.0) 
53 (88.3) 
7 (11.7) 
60 (100.0) 
 
HISTORY OF PREVIOUS 
PREGNANCIES 
   0.078 
First pregnancy 
Multiple pregnancies 
Total 
75 (38.46) 
120 (61.53) 
195 (100.0) 
32 (33.0) 
65 (67.0) 
97 (100.0) 
43 (43.9) 
55 (56.1) 
98 (100.0) 
 
PREVIOUS PRE-TERM BIRTH    0.000 
Yes 
No 
Total 
32 (16.0) 
101 (50.5) 
133 (100.0) 
8 (11.1) 
64 (88.9) 
72 (100.0) 
24 (39.3) 
37 (60.7) 
61 (100.0) 
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History of previous pregnancies 
 
A total of 195 (97.5 %) mothers reported on previous pregnancies (Table 8). Although 
women in their first pregnancy appeared to be more likely to deliver PLBW than women 
who reported multiple pregnancies (Table 8), this difference was not found to be statistically 
significant (p = 0.078).  
 
However, when looking at a history of previous pregnancies, a very good correlation (p = 
0.000) was observed between history of previous PLBW and present PLBW (Table 8). 
Mothers with a history of previous PLBW were more likely to deliver PLBW infants in 
subsequent pregnancies. Only 133/200 mothers responded to this question so we have no 
record of the other 67 patients. 
 
3.5. LIVING CONDITIONS  
 
Length of time spent in a particular domain 
 
The stability of length of time spent in a particular domain did not appear to affect 
pregnancy outcomes (p = 0.995). Most of the patients 130 (67.01 %) lived in their present 
address for less than 5 years, 38 (19.58 %) between 5 and 10 years and only 26 (13.40 %) 
lived in their present address for more than 10 years (Table 9). Six (3 %) of them did not 
respond to this question. 
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Table 9: Conditions of life in the house 
CHARACTERISTICS FREQUENCY (%) NORMAL BIRTH 
n (%) 
PLBW n (%) p value 
Duration in the present address    0.995 
< 5 years 
5 – 10 years 
> 10 years 
Total  
130(67.01) 
38(19.58) 
26(13.40) 
194(100.0) 
66 (67.3) 
19 (19.4) 
13 (13.3) 
98 (100.0) 
64 (66.7) 
19 (19.8) 
13 (13.5) 
96 (100.0) 
 
Number of  family members    0.029 
0 – 1 people 
2 people 
3 people 
4 people 
5 people 
6 people and more 
Total 
15(8.02) 
36(19.25) 
43(22.99) 
35(18.71) 
22(11.76) 
36(19.25) 
187(100.0) 
4 (4.2) 
14 (14.6) 
25 (26.0) 
15 (15.6) 
15 (15.6) 
23 (24.0) 
96 (100.0) 
11 (12.1) 
22 (24.2) 
18 (19.8) 
20 (22.0) 
7 (7.7) 
13 (14.3) 
91 (100.0) 
 
Number of children    0.064 
No child 
1 child 
2 children 
3 children 
4 children and more 
Total 
 
35(19.12) 
71(38.79) 
38(20.76) 
15(8.19) 
24(13.11) 
183(100.0) 
 
13 (14.0) 
37 (39.8) 
17 (18.3) 
12 (12.9) 
14 (15.1) 
93 (100.0) 
22 (24.4) 
34 (37.8) 
21 (23.3) 
3 (3.3) 
10 (11.1) 
90 (100.0) 
 
 
Number of family members 
 
Table 9 shows a significant correlation (p= 0.029) between number of family members and 
PLBW. It would generally appear that when there were 2 - 4 people in the house, they were 
more likely to deliver PLBW while those living ≥ 5 in the house were more likely to deliver 
a full term baby.  
 
Number of children 
 
No significant correlation (p=0.064) was observed between number of children and PLBW, 
although PLBW was increased in the 35 mothers who delivered their first child (Table 9). 
Only 183/200 mothers (91.5 %) reported on the number of other children in their families.  
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3.6. DENTAL HISTORY OF THE MOTHER 
 
When asked about the frequency of visits to the dentist, 135 (71.42 %) of the participants 
reported that they never visit a dentist while less than half reported visiting the dentist once 
or twice a year. There was no significant difference (p = 0.063) between normal birth and 
PLBW in either of these groups (Table 10).  
 
Table 10: Dental History of the Mother 
CHARACTERISTICS FREQUENCY (%) NORMAL BIRTH 
n (%) 
PLBW n (%) p value 
FREQUENCY OF DENTAL VISITS:    0.063 
Never 
Once a year 
Twice a year 
Whenever 
Total 
135 (71.42) 
42 (22.22) 
8 (4.23) 
4 (2.11) 
189 (100.0) 
61 (62.9) 
28 (28.9) 
5 (5.2) 
3 (3.1) 
97 (100.0) 
74 (80.4) 
14 (15.2) 
3 (3.3) 
1 (1.1) 
92 (100.0) 
 
ACCESS TO MEDICAL OR DENTAL 
CARE 
   0.063 
Yes 
No 
Total 
33 (17.01) 
161 (85.18) 
194 (100.0) 
19 (19.6) 
78 (80.4) 
97 (100.0) 
14 (14.4) 
83 (85.6) 
97 (100.0) 
 
GINGIVAL INFLAMMATION AND 
BLEEDING 
   0.004 
Yes 
No 
Total 
104 (55.02) 
85 (44.97) 
189 (100.0) 
45 (45.5) 
54 (54.5) 
99 (100.0) 
59 (65.6) 
31 (34.4) 
90 (100.0) 
 
FREQUENCY OF TOOTH BRUSHING    0.352 
Once a day 
Twice a day 
After every meal 
Total 
92 (59.35) 
58 (37.41) 
5 (3.22) 
155 (100.0) 
44 (58.7) 
27 (36.0) 
4 (5.3) 
75 (100.0) 
48 (60.0) 
31 (38.8) 
1 (1.2) 
80 (100.0) 
 
BLEEDING WHILE BRUSHING    0.522 
Yes 
No 
Total 
99 (61.11) 
63 (38.88) 
162 (100.0) 
48 (61.5) 
30 (38.5) 
78 (100.0) 
51 (60.7) 
33 (39.3) 
84 (100.0) 
 
PAIN WHILE BRUSHING    0.104 
Yes 
No 
Total 
 
40 (26.14) 
113 (73.85) 
153 (100.0) 
23 (31.5) 
50 (68.5) 
73 (100.0) 
17 (21.2) 
63 (78.8) 
80 (100.0) 
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One hundred and ninety-four (97 %) provided information on access to medical and dental 
care. The majority reported having no access to medical and dental care, and although this 
factor did not appear to directly influence the gestation period and birth weight of the infants 
(p = 0.063), the presence of gingival inflammation and bleeding clinically observed in these 
mothers, showed a significant correlation (p = 0.004) with PLBW (Table 10). 
 
Frequency of tooth brushing 
 
Frequency of brushing did not appear to be associated with normal birth or PLBW outcome 
(p= 0.352). Of the 155 participants who reported on the frequency of tooth brushing, 92 
(59.35 %) claimed they brushed once a day, 58 (37.41 %) reported twice a day and 5 (3.22 
%) reported that they brushed after every meal (Table 10).  
 
Bleeding and pain while brushing teeth 
 
Forty (26.14 %) reported pain, and 99 (61.11 %) reported bleeding while brushing their 
teeth, while 113 (73.85 %) and 63 (38.88 %) reported neither pain nor bleeding when 
brushing their teeth (Table 10). No significant differences could be established in either of 
these categories for adverse pregnancy outcomes (p = 0.522 and p = 0.104 respectively). 
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3.7. DISCUSSION 
 
Not all of the 200 mothers examined responded to all of the questions in the questionnaire 
with the result that we were not able to determine whether their responses were indeed 
negative or whether they were reluctant to provide the information requested.  
 
The physical condition of the mothers who responded to the questions on age, height and 
weight could be summarized as follows: age appeared to influence pregnancy outcomes but 
not significantly so (p=0.557), while a significant correlation was observed between 
maternal weight and PLBW (p=0.006), and maternal height and PLBW (p= 0.041). Earlier 
studies showed that the frequency of preterm delivery was higher in mothers below 18 years 
and above 35 years of age (Martius et al., 1998; Astoffi and Zonta, 1999; Goldenberg 1998, 
2008; American College of  Obstetricians and Gynecologists, 2001), and it can be expected, 
as previously reported, that women with a poor nutritional status are at greater risk for 
preterm delivery (Hendler et al., 2005), because the thinner the mother, the weaker she 
would be and thus less able to carry full term (Mavalankar et al., 1994; Siega-Riz et al., 
1995; Sekiya et al., 2007; Chan and Lao, 2009).   
 
Education plays a major role in providing information on nutrition and health care. It has 
been suggested in the literature that mothers with no formal education are more likely to 
deliver PLBW (Goldenberg et al., 2008; Astoffi and Zonta, 1999). In this study group, 
mothers who attended secondary school and university were more likely to deliver full term 
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and normal weight than PLBW infants, although this association was not significant 
(p=0.355).  
 
Earlier researchers reported a relationship between diabetes, heart disease and PLBW 
(Samadi and Mayberry, 1998; Xiong et al., 2001; Hedderson et al., 2003), but no correlation 
was found in this group. However, few mothers responded to all the questions asked, thus 
making it difficult to draw any final conclusions (only 3 cases for diabetes and 19 for heart 
disease). The impact of smoking and alcohol consumption on maternal health and therefore 
on pregnancy outcomes, remains uncertain. Contrary to previous studies (Vitoratos et al., 
1997; Lundsberg et al., 1997; Kyrklund-Blomberg et al., 2005; American College of 
Obstetricians and Gynecologists, 2001; Moore and Zaccaro, 2000; Odendaal et al., 2009), 
we found no correlation between alcohol consumption (p =0.337) or smoking (p =0.506) 
and PLBW in this study. Only 24 reported daily alcohol consumption and of these, 14 
(58.33 %) had PLBW and 10 (14.66 %) had normal infants. Although a very low level of 
alcohol consumption has been associated with pregnancy outcome (Cogswell et al., 2003), 
the weekly and special occasion alcohol consumption of the mothers in this study had no 
negative outcomes for pregnancy.  
 
No significant correlation (p = 0.079) was observed in this study between antibiotic 
administration and PLBW although the results show that mothers who took antibiotics while 
pregnant had more PLBW deliveries than those who didn’t. Other studies examining the use 
of antibiotics have also provided mixed results, with some showing no major benefit while 
others do (Lamont, 2005; McDonald et al., 2007; Iams et al., 2008). An important factor to 
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consider would be whether the antibiotics were administered to treat an infection or whether 
it was a prophylactic administration to mothers at risk for adverse pregnancy outcomes.  
It is a known fact that infection can predispose a mother to adverse pregnancy outcomes  
(Hillier et al., 1995; American College of Obstetricians and Gynecologists, 2001; Wadhwa, 
et al., 2001; Goldenberg, 2002). In this study, mothers who had sexually transmitted disease 
and urinary tract infections had more PLBW than normal infants, but these correlations were 
not statistically significant. 
 
No significant correlation was found (p=0.078) between first, multiple pregnancies and 
PLBW, although the results concur with previous studies which showed that PLBW seemed 
to be more likely to occur when women were in their first pregnancy (Astoffi and Zonta, 
1999) and that mothers with a history of previous PLBW were significantly (p = 0.0000) at 
higher risk for another preterm birth (Mercer et al., 1999; American College of Obstetricians 
and Gynecologists, 2001).  
 
An association between poor health condition of children in the family and PLBW was 
observed (p=0.003). Whether this can be attributed to the fact that poor health resulted from 
PLBW or whether PLBW occurred as a result of poor nutrition is not clear. It is known that 
poor maternal nutritional status is a very important factor for preterm birth  resulting in 
delivery of PLBW infants who are exposed to serious health problems (Hendler et al., 
2005). 
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Oral health care during pregnancy is vital to the prognosis of pregnancy outcomes. 
Offenbacher et al., (2006), found that women who received dental care or treatment before 
or during their pregnancy had 50 % lower risk of delivering PLBW while some recent 
studies found that treatment for periodontal disease did not reduce the rate of preterm birth 
(PTB) (Michalowicz et al., 2006; Offenbacher et al., 2009; Jeffcoat, 2010, Niederman, 
2010). In this study, no significant correlations were found between maternal oral hygiene 
habits (such as tooth brushing and dental visits), nor  pain and bleeding (while brushing 
teeth) and PLBW. The reasons for lack of dental visitations may include poverty, ignorance 
and culture. A good association between gingival inflammation and PLBW (p = 0.004) was 
found as in earlier studies (Hill 1998; Dasanayake et al., 2001, Madianos et al., 2001; 
Dörtbudak et., 2005; Lin et al., 2007), while this was not the case when comparing mothers 
with PLBW infants and the control group in a study by Jarjoura et al (2005). 
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 CHAPTER 4: PCR DETECTION OF SUSPECTED 
PERIODONTOPATHOGENS  IN GINGIVAL CREVICULAR FLUID              
                              
4.1. INTRODUCTION 
 
The microbial aetiology of periodontal disease is best explained by the ecological shifts 
which take place in the dental plaque biofilm. As bacterial plaque accumulates, the 
inflammatory cells increase in number causing the gingival tissues to bleed, swell, and 
become edematous. Streptococci are normally the initial colonizers. Nutrients needed by 
other microbes such as the suspected periodontopathogens become increasingly available 
due to the bleeding and tissue inflammation initiated by the initial colonizers hence 
promoting their proliferation (Loesche et al., 2001). Various host anti-inflammatory 
responses against the bacteria are initiated, which can be both destructive and protective to 
the host's tissues. Among the protective responses are included the removal of bacterial 
products such as antigens, LPS and enzymes. However, the host's inflammatory response 
also includes the activation of matrix metalloproteases agents responsible for collagen loss 
in tissues. Such collagen loss leads to attachment loss, thereby deepening the depression 
where gingival tissues contact the tooth surface. This further deepening creates the 
periodontal pocket. The loss of attachment defines the difference between gingivitis and 
periodontitis.  
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As one of the objectives of this study was to assess the relationship between proposed risk 
factors for periodontal disease and PLBW, the detection and identification of suspected 
anaerobic periodontopathogens from the mother was of great importance. Gingival 
crevicualar fluid (GCF), which is a mixture of substances derived from serum, leuckocytes, 
structural cells of the periodontium and oral bacteria (Uitto, 2003), was collected from the 
mother as explained in Chapter 2. Five periodontopathic bacteria (Porphyromonas 
gingivalis, Treponema denticola, Prevotella intermedia, Fusobacterium nucleatum, 
Aggregatibacter actinomycetemcomitans) most frequently associated with periodontal 
disease and among the suspected periodontopathogens associated with PLBW, were the 
target of this study. Polymerase Chain Reaction (PCR) was used to achieve this objective.  
 
4.2. PREVALENCE OF THE FIVE SUSPECTED PERIODONTOPATHOGENS IN GCF 
AS DETECTED BY PCR 
 
Examples of PCR detection of the six periodontopathogens are demonstrated in Figures 1-5. 
Table 11 reports on their prevalence in GCF. The following abbreviations will be used for 
all the tables which follow:  Pg =  Porphyromonas gingivalis, Td = Treponema denticola, 
Pi = Prevotella intermedia, Fn = Fusobacterium nucleatum, Aa = Aggregatibacter  
actinomycetemcomitans, P = Positive and N = Negative. Adjusting for missing data, the 
valid % positive will be described for each species. The same adjustment will be used for 
reporting on the frequency of species in all of the Tables.  
 
 
 
 
 
 46
F. nucleatum was the most prevalent (86.2 %), followed by P. intermedia (73.5 %), A. 
actinomycetemcomitans (Aa, 45 %), P. gingivalis (28.4%) and T. denticola (24.3 %) as 
shown in Table 11.  
 
When examining for their presence in pairs, the valid % of positive combinations in terms of 
frequency were Pi / Fn (64.0 %), followed by the combinations  Aa / Fn (41.3 %) and Td / 
Aa (12.7 %).  Combinations of three showed the most frequent combinations as Pi / Aa / Fn 
(30.7 %), Td / Pi / Fn (20.1 %), Pg / Pi / Fn (19.0 %) and Td / Pi / Aa (12.2 %). The only 
combination of four was Td/Pi/Aa/Fn.  
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Table 11: Prevalence of the five suspected peridontopathogens in maternal GCF 
 
Bacterial species Positive n (%) Negative n (%) Missing n (%) Valid Percentage 
Positive 
P. gingivalis (Pg) 54 (27.0) 136 (68.0) 10 (5.0) 28.4 
T. denticola (Td) 46 (23.0) 143 (71.5) 11 (5.5) 24.3 
P. intermedia (Pi) 139 (69.5) 50 (25.0) 11 (5.5) 73.5 
A. actinomycetemcomitans (Aa) 85 (42.5) 104 (52.0) 11 (5.5) 45 
F. nucleatum (Fn) 163 (81.5 26 (13.0) 11 (5.5) 86.2 
Pg / Td 27 (13.5) 163 (81.5) 12 (6.0) 14.2 
Pg / Pi 45 (22.5) 143 (71.5) 12 (6.0) 23.9 
Pg / Aa 27 (13.5) 161 (80.5) 12 (6.0) 14.4 
Pg / Fn 42 (21.0) 146 (73.0) 12 (6.0) 22.3 
Td / Pi 43 (21.5) 146 (73.0) 11 (5.5) 22.8 
Td / Aa 24 (12.0) 165 (82.5) 11 (5.5) 12.7 
Td / Fn 41 (20.5) 148 (74.0) 11 (5.5) 21.7 
Pi  / Aa 64 (32.0) 125 (62.5) 11 (5.5) 33.9 
Pi / Fn 121 (60.5) 68 (34.0) 11 (5.5) 64.0 
Aa / Fn 78 (39.0) 111 (55.5) 11 (5.5) 41.3 
Pg / Td / Pi 26 (13.0) 163 (81.) 11 (5.5) 13.8 
Pg / Td / Aa 27 (13.5) 162 (81.0) 11 (5.5) 14.3 
Pg / Td / Fn 23 (11.5) 166 (83.0) 11 (5.5) 12.2 
Pg / Pi /  Aa 24 (12.0) 165 (82.5) 11 (5.5) 12.7 
Pg / Pi / Fn 36 (18.0) 153 (76.5) 11 (5.5) 19.0 
Pg / Aa / Fn 23 (11.5) 166 (83.0) 11 (5.5) 12.2 
Td /Pi / Aa 23 (11.5) 166 (83.0) 11 (5.5) 12.2 
Td / Pi / Fn 38 (19.0) 151 (75.5) 11 (5.5) 20.1 
Pi / Aa / Fn  58 (29.0) 131 (65.5) 11 (5.5) 30.7 
Td / Pi / Aa / Fn 22 (11.0) 167 (83.5) 11 (5.5) 11.6 
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Figure 1: PCR amplification of P. gingivalis  using Species-specific primers 
Expected product size: 404 bp, lane 1: DNA marker 100 bp, lane 2 (Gel 1): positive control, 
lane 3 (Gel 1): negative control. 
 
 
Figure  2: PCR amplification of T. denticola using Species-specific primers 
Expected product size: 316 bp, lane 1: DNA marker 100 bp, lane 2 (gel 1): positive control, 
lane 3 (gel 1): negative control. 
 
   1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728 
1   2    3    4    5     6    7    8    9   10  11  12  13 14  15   16   17  18   19  20 
500bp 
500bp 
Gel 1 
Gel 2 
Gel 1 
Gel 2 
500bp 
500bp 
    1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728 
   1   2   3    4    5   6   7    8    9  10  11  12  13  14  15  16  17  18  19 20 
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Figure 3: PCR amplification of P. intermedia using Species-specific primers 
Expected product size: 307 bp, lane 1: DNA marker 100 bp, lane 2 (gel 1): positive control, 
lane 3 (gel 1): negative control. 
 
Figure 4: PCR amplification of A. actinomycetemcomitans using Species-specific 
primers. Expected product size: 500 bp, lane 1: DNA marker 100 bp, lane 2 (gel 1): positive 
control, lane 3 (gel 1): negative control. 
 
 
 
 
    1   2   3    4    5   6   7    8    9  10  11  12  13  14  15  16  17  18  19  20 
     1  2  3  4  5  6  7  8  9  1011 121314 1516171819 20212223 24252627 28 
Gel 1 
Gel 2 
500bp 
500bp 
 1     2   3     4    5    6    7    8    9    10  11  12  13  14   15   16  17  18   19   20 
Gel 2 
Gel 1 
500bp 
500bp 
  1  2  3  4 5  6  7  8 9   10 1112 131415 16 17 1819202122 2324 2526 2728 
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Figure 5: PCR amplification of F. nucleatum using Species-specific primers 
Expected product size: 705 bp, lane 1: DNA marker 100 bp, lane 2 (gel 1): positive control, 
lane 3 (gel 1): negative control.
Gel 2 
Gel 1 
500bp 
500bp 
  1      2     3      4     5      6     7      8      9    10    11   12   13    14     15   16   17    18    19    20 
   1   2   3   4  5   6   7   8  9  10  11 12 13  14 15 16  17  18 19  20  21 22  23 24  25 26  27 28 
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4.3. ASSOCIATION BETWEEN AGE AND THE FIVE ANAEROBIC 
PERIODONTOPATHOGENS 
 
No significant association could be observed between the age of the mother and the presence 
of any one of the five anaerobic periodontopathogens when they were detected singly. The p 
values were 0.258, 0.110, 0.640, 0.229, 0.096 and 0.513 respectively for P. gingivalis, T. 
denticola, P. intermedia, A. actinomycetemcomitans, and F. nucleatum (Table 12). 
However, a significant association was observed between age and the following paired 
combination Pi/Aa (p value: 0.027).The frequency decreased in the age groups ≤ 20 and 31-
35 years, with a slight increase in the age group of ≥ 36 years. No significant association 
was observed between age and combinations of three or more bacteria (Table 12). 
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Table 12: Correlation between age and the five anaerobic periodontopathogens  
 
Bacterial species ≤  20 years  
n /15 (%) 
21 - 25yrs  
n /57 (%) 
26 - 30yrs  
n /57 (%) 
31 - 35yrs  
n /35 (%) 
≥ 36yrs  
n /22 (%) 
p value 
P g 3 (20.0) 13 (22.8) 18 (31.6) 15 (42.9) 5 (22.7) 0.258 
T.d 3 (20.0) 14 (24.6) 17 (29.8) 6 (17.1) 4 (18.2) 0.640 
P i 13 (86.7) 46 (80.7) 37 (64.9) 24 (68.6) 17 (77.3) 0.229 
Aa 10 (66.7) 30 (52.6) 19 (33.3) 14 (40.0) 11 (50.0) 0.096 
F n 12 (80.0) 49 (86.0) 50 (87.75) 28 (80.0) 21 (95.5) 0.513 
Pg / Td 2 (13.33) 6 (10.5) 12 (21.15) 4 (11.4) 3 (13.36) 0.564 
Pg / Pi 2 (13.33) 12 (21.1) 18 (31.65) 8 (22.95) 5 (22.7) 0.592 
Pg / Aa 3 (20.0) 6 (10.5) 7 (12.3) 6 (17.15) 5 (22.7) 0.579 
Pg / Fn 2 (13.3) 8 (14.0) 15 (26.3) 13 (37.1) 4 (18.2) 0.097 
Td / Pi 3 (20.0) 14 (24.6) 16 (28.1) 5 (14.3) 4 (18.2) 0.594 
Td / Aa 3 (20.0) 8 (14.0) 5 (8.8) 5 (14.3) 3 (13.6) 0.796 
Td / Fn 2 (13.3) 13 (22.8) 14 (24.6) 6 (17.1) 4 (18.2) 0.827 
Pi  / Aa 9 (60.0) 24 (42.1) 12 (21.1) 10 (28.6) 8 (36.4) 0.027 
Pi / Fn 10 (66.7) 40 (70.2) 33 (57.9) 20 (57.15) 16 (72.7) 0.501 
Aa / Fn 8 (53.3) 27 (47.4) 19 (33.3) 13 (37.1) 10 (45.5) 0.454 
Pg / Td / Pi 2 (13.3) 6 (10.5) 12 (21.1) 3 (8.6) 3 (13.6) 0.434 
Pg / Td / Aa 2 (13.3) 6 (10.5) 12 (21.1) 4 (11.4) 3 (13.6) 0.559 
Pg/ Td / Fn 1 (6.7) 5 (8.8) 10 (17.5) 4 (11.4) 3 (13.6) 0.627 
Pg /Pi /  Aa 2 (13.3) 6 (10.5) 7 (12.3) 4 (11.4) 5 (22.7) 0.687 
Pg / Pi / Fn 1 (6.7) 8 (14.0) 15 (26.3) 8 (22.9) 4 (18.2) 0.326 
Pg / Aa /Fn 2 (13.3) 4 (7.0) 7 (12.3) 6 (17.1) 4 (18.2) 0.568 
Td /Pi / Aa 3 (20.0) 8 (14.0) 5 (8.8) 4 (11.4) 3 (13.6) 0.792 
Td / Pi / Fn 2 (13.3) 13 (22.8) 13 (22.8) 5 (14.3) 4 (18.2) 0.783 
Pi / Aa / Fn  7 (46.7) 21 (36.8) 12 (21.1) 10 (28.6) 7 (31.8) 0.249 
Td / Pi / Aa / Fn 2 (13.3) 8 (14.0) 5 (8.8) 4 (11.4) 3 (13.6) 0.927 
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4.4. CORRELATION BETWEEN LEVELS OF EDUCATION AND THE FIVE   
       PERIODONTOPATHOGENS  
 
A significant association was observed between educational levels and the presence of  T. 
denticola (p = 0.047, Table 13), whether detected singly or in combination with other 
species. When detected in pairs (Table 13), only Pg / Td showed a significant association 
with the level of education (p = 0.001), while other significantly associated combinations 
included Pg / Td / Pi (p = 0.000), Pg / Td / Aa (p = 0.001) and Pg / Td / Fn (p = 0.003), 
(Table 13). 
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Table 13: Correlation between level of education and the five periodontopathogens  
 
Bacterial species No education  
n /18 (%) 
Primary school  
n /111 (%) 
High School  
n /42 (%) 
University  
n /15 (%) 
p value 
Pg 7(38.9) 32 (28.82) 8 (19.0) 6 (40.0) 0.286 
Td 7 (38.9) 24 (21.6) 7 (16.7) 7 (46.7) 0.047 
Pi 17 (94.4) 84 (75.7) 28 (66.7) 9 (60.0) 0.078 
Aa 9 (50.0) 52 (46.8) 17 (40.5) 5 (33.3) 0.683 
Fn 16 (88.9) 95 (85.6) 36 (85.7) 13 (86.7) 0.985 
Pg / Td 6 (33.3) 11 (9.9) 3 (7.1) 6 (40.0) 0.001 
Pg / Pi 7 (38.9) 25 (22.52) 6 (14.3) 6 (40.0) 0.086 
Pg / Aa 3 (16.7) 15 (13.51) 5 (11.9) 4 (26.7) 0.544 
Pg / Fn 6 (33.3) 25 (22.52) 5 (11.9) 5 (33.3) 0.174 
Td / Pi 7 (38.9) 22 (19.8) 7 (16.7) 6 (40.0) 0.083 
Td / Aa 3 (16.7) 12 (10.8) 5 (11.9) 4 (26.7) 0.358 
Td / Fn 6 (33.3) 22 (19.8) 6 (14.3) 6 (40.0) 0.111 
Pi  / Aa 8 (44.4) 39 (35.1) 13 (31.0) 4 (26.7) 0.694 
Pi / Fn 15 (83.3) 71 (64.0) 26 (61.9) 8 (53.3) 0.291 
Aa / Fn 7 (38.9) 49 (44.1) 15 (35.7) 5 (33.3) 0.721 
Pg / Td / Pi 6 (33.3) 10 (9.0) 3 (7.1) 6 (40.0) 0.000 
Pg / Td / Aa 6 (33.3) 11 (9.9) 3 (7.1) 6 (40.0) 0.001 
Pg / Td / Fn 5 (27.9) 10 (9.0) 2 (4.8) 5 (33.3) 0.003 
Pg / Pi / Aa 3 (16.7) 13 (11.7) 4 (9.5) 4 (26.7) 0.345 
Pg / Pi / Fn 6 (33.3) 20 (18.0) 4 (9.5) 5 (33.3) 0.073 
Pg / Aa / Fn 2 (11.1) 13 (11.7) 4 (9.5) 4 (26.7) 0.360 
Td / Pi / Aa 3 (16.7) 11 (9.9) 5 (11.9) 4 (26.87) 0.288 
Td / Pi / Fn 6 (33.3) 20 (18.0) 6 (14.3) 5 (33.3) 0.186 
Pi / Aa / Fn 6 (33.3) 36 (32.4) 12 (28.6) 4 (26.7) 0.941 
Td / Pi / Aa / Fn 2 (11.1) 11 (9.9) 5 (11.9) 4 (26.7) 0.312 
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4.5. CORRELATION BETWEEN DENTAL HISTORY AND THE FIVE   
       PERIODONTOPATHOGENS  
 
P.intermedia was the only single species which showed a significant association (p= 0.045) 
with frequency of tooth brushing (Table 14). No association was observed between 
frequency of tooth brushing and detection of suspected periodontopathogens in 
combinations of five and six (Table 14). 
 
No statistically significant association was observed between the single periodontopathogens 
and gum bleeding while brushing, although the frequency of positive results in patients 
reporting gum bleeding was higher than those who did not bleed while brushing (Table 15). 
The following pairs: Pg / Aa and Td / Aa showed a good association with gum bleeding (p = 
0.041 and 0.032 respectively) and again, positive results in patients with gum bleeding were 
higher than those who reported no bleeding while brushing (Table 15). Combinations of 
three or four, namely, Pg / Pi / Aa, Td / Pi / Aa, and Td / Pi / Aa / Fn showed a significant 
association with gum bleeding (p = 0.022, 0.032 and 0.046 respectively. Although the 
frequency of positive results was slightly higher in patients with gum pain than those who 
reported no gum pain when brushing (Table 16), no significant association was observed. 
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Table 14: Correlation between frequency of tooth brushing and the five 
periodontopathogens. 
Bacterial species Once a day  
n /87 (%) 
Twice a day  
n /55 (%) 
After every meal  
n /5 (%) 
p value 
Pg 26 (29.88) 14 (25.5) 2 (40.0) 0.733 
Td 21 (24.1) 15 (27.3) 1 (20.0) 0.883 
Pi 70 (80.5) 37 (67.3) 2 (40.0) 0.045 
Aa 34 (39.1) 25 (45.5) 1 (20.0) 0.176 
Fn 74 (85.1) 45 (81.8) 5 (100.0) 0.541 
Pg / Td 11 (12.64) 7 (12.7) 1 (20.0) 0.887 
Pg / Pi 22 (25.28) 10 (18.2) 2 (40.0) 0.399 
Pg / Aa 12 (13.79) 6 (10.9) 2 (40.0) 0.193 
Pg / Fn 19 (21.83) 10 (18.2) 2 (40.0) 0.497 
Td / Pi 20 (23.0) 14 (25.5) 1 (20.0) 0.962 
Td / Aa 10 (11.5) 8 (14.5) 1 (20.0) 0.775 
Td / Fn 17 (19.5) 14 (25.5) 1 (20.0) 0.704 
Pi  / Aa 29 (33.3) 18 (32.7) 2 (40.0) 0.947 
Pi / Fn 60 (69.0) 32 (58.2) 2 (40.0) 0.225 
Aa / Fn 31 (35.6) 23 (41.8) 1 (20.0) 0.129 
Pg / Td / Pi 11 (12.6) 7 (12.7) 1 (20.0) 0.891 
Pg / Td / Aa 11 (12.6) 7 (12.7) 1 (20.0) 0.891 
Pg / Td / Fn 8 (9.2) 6 (10.9) 1 (20.0) 0.723 
Pg / Pi / Aa 12 (13.8) 4 (7.3) 2 (40.0) 0.080 
Pg / Pi / Fn 17 (19.5) 7 (12.7) 2 (40.0) 0.241 
Pg / Aa / Fn 9 (10.3) 6 (10.9) 2 (40.0) 0.129 
Td / Pi / Aa 10 (11.5) 8 (14.5) 1 (20.0) 0.775 
Td / Pi / Fn 16 (18.4) 13 (23.6) 1 (20.0) 0.752 
Pi / Aa / Fn 26 (29.9) 17 (30.9) 2 (40.0) 0.891 
Td / Pi / Aa / Fn 9 (10.3) 8 (14.5) 1 (20.0) 0.656 
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Table 15: Correlation between gum bleeding and the five periodontopathogens  
Bacterial species YES  
n/97 (%) 
NO  
n/57 (%) 
p value 
Pg 30 (30.9) 15 (26.31) 0.314 
Td 28 (28.9) 10 (17.5) 0.082 
Pi 75 (77.3) 38 (66.7) 0.105 
Aa 47 (48.5) 20 (35.1) 0.073 
Fn 81 (83.5) 49 (86.0) 0.436 
Pg / Td 15 (15.5) 5 (8.77) 0.163 
Pg / Pi 26 (26.8) 11 (19.29) 0.213 
Pg / Aa 18 (18.6) 4 (7.01) 0.041 
Pg / Fn 19 (19.6) 14 (24.56) 0.279 
Td / Pi 27 (27.8) 9 (15.8) 0.064 
Td / Aa 16 (16.5) 3 (5.3) 0.032 
Td / Fn 24 (24.7) 9 (15.8) 0.134 
Pi  / Aa 37 (38.1) 14 (24.6) 0.059 
Pi / Fn 63 (64.9) 34 (59.6) 0.313 
Aa / Fn 41 (42.3) 20 (35.1) 0.240 
Pg / Td / Pi 15 (15.5) 5 (8.8) 0.173 
Pg / Td / Aa 15 (15.5) 5 (8.8) 0.173 
Pg / Td / Fn 12 (12.4) 4 (7.0) 0.221 
Pg / Pi / Aa 17 (17.5) 3 (5.3) 0.022 
Pg / Pi / Fn 18 (18.6) 10 (17.5) 0.528 
Pg / Aa / Fn 14 (14.4) 4 (7.0) 0.129 
Td / Pi / Aa 16 (16.5) 3 (5.3) 0.032 
Td / Pi / Fn 23 (23.7) 8 (14.0) 0.107 
Pi / Aa / Fn 32 (33.0) 14 (24.6) 0.179 
Td / Pi / Aa / Fn 15 (15.5) 3 (5.3) 0.046 
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Table 16: Correlation between pain while brushing and the five periodontopathogens  
Bacterial species YES n/39 (%) NO n/108 (%) p value 
Pg 12 (30.8) 30 (27.8) 0.436 
Td 11 (28.2) 25 (23.1) 0.335 
Pi 31 (79.5) 78 (72.2) 0.253 
Aa 19 (48.7) 45 (41.7) 0.283 
Fn 34 (87.2) 90 (83.3) 0.389 
Pg / Td 6 (15.4) 12 (11.1) 0.330 
Pg / Pi 10 (25.6) 24 (22.22) 0.420 
Pg / Aa 8 (20.5) 13 (12.03) 0.157 
Pg / Fn 9 (23.1) 22 (20.37) 0.452 
Td / Pi 11 (28.2) 23 (21.3) 0.253 
Td / Aa 7 (17.9) 12 (11.1) 0.205 
Td / Fn 10 (25.6) 22 (20.4) 0.318 
Pi  / Aa 15 (38.5) 35 (32.4) 0.311 
Pi / Fn 27 (69.2) 67 (62.0) 0.274 
Aa / Fn 18 (46.2) 40 (37.0) 0.209 
Pg / Td / Pi 6 (15.4) 12 (11.1) 0.330 
Pg / Td / Aa 6 (15.4) 12 (11.1) 0.330 
Pg / Td / Fn 6 (15.4) 9 (8.3) 0.173 
Pg / Pi / Aa 7 (17.9) 12 (11.1) 0.330 
Pg / Pi / Fn 8 (20.5) 18 (16.7) 0.376 
Pg / Aa / Fn 7 (17.9) 10 (9.3) 0.124 
Td / Pi / Aa 7 (17.9) 12 (11.1) 0.205 
Td / Pi / Fn 10 (25.6) 20 (18.5) 0.234 
Pi / Aa / Fn 14 (35.9) 31 (28.7) 0.261 
Td / Pi / Aa / Fn 7 (17.9) 11 (10.2) 0.359 
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4.6. CORRELATION BETWEEN SMOKING, ALCOHOL CONSUMPTION AND  
       THE FIVE PERIODONTOPATHOGENS 
   
Neither alcohol nor smoking could be associated with the presence of the five 
periodontopathogens (Table 17 and 18). However, the number of patients who reported 
smoking may be too small for a definite conclusion to be drawn. 
Table 17: Correlation between alcohol consumption and the presence of suspected 
periodontopathogens  
Bacterial species Never  
n/91 (%) 
Daily  
n/24 (%) 
Weekly  
n/28 (%) 
Special 
occasion  
n/35 (%)  
p value 
Pg 27 (29.67) 5 (20.8) 10 (35.7) 11 (31.42) 0.676 
Td 24 (26.4) 6 (25.0) 4 (14.3) 10 (28.6) 0.562 
Pi 69 (75.8) 20 (83.3) 22 (78.6) 23 (65.7) 0.434 
Aa 36 (39.6) 14 (58.3) 12 (42.9) 18 (51.4) 0.327 
Fn 75 (82.4) 23 (95.8) 25 (89.3) 29 (82.9) 0.353 
Pg / Td 13 (14.28) 2 (8.3) 3 (10.7) 8 (22.85) 0.346 
Pg / Pi 23 (25.3) 5 (20.8) 8 (28.6) 8 (22.85) 0.929 
Pg / Aa 11 (12.1) 3 (12.5) 4 (14.3) 8 (22.85) 0.439 
Pg / Fn 20 (22.0) 4 (16.7) 8 (28.6) 9 (26.5) 0.727 
Td / Pi 24 (26.4) 5 (20.8) 4 (14.3) 8 (22.85) 0.605 
Td / Aa 12 (13.2) 2 (8.3) 2 (7.1) 6 (17.1) 0.602 
Td / Fn 20 (22.0) 6 (25.0) 4 (14.3) 9 (25.71) 0.710 
Pi  / Aa 30 (33.0) 11 (45.8) 8 (28.6) 12 (34.3) 0.594 
Pi / Fn 58 (63.7) 19 (79.2) 20 (71.4) 19 (54.3) 0.216 
Aa / Fn 33 (36.3) 13 (54.2) 11 (39.3) 16 (45.7) 0.404 
Pg / Td / Pi 13 (14.28) 2 (8.3) 3 (10.7) 7 (20.0) 0.585 
Pg / Td / Aa 13 (14.28) 2 (8.3) 3 (10.7) 8 (22.9) 0.389 
Pg / Td / Fn 10 (11.0) 2 (8.3) 3 (10.7) 7 (20.0) 0.480 
Pg / Pi / Aa 11 (12.1) 3 (12.5) 3 (10.7) 6 (17.1) 0.865 
Pg / Pi / Fn 17 (18.7) 4 (16.7) 7 (25.0) 7 (20.0) 0.873 
Pg / Aa / Fn 9 (9.9) 2 (8.3) 3 (10.7) 8 (22.9) 0.212 
Td / Pi / Aa 12 (13.2) 2 (8.3) 2 (7.1) 5 (14.3) 0.744 
Td / Pi / Fn 20 (22.0) 5 (20.8) 4 (14.3) 7 (20.0) 0.851 
Pi / Aa / Fn 28 (30.8) 10 (41.7) 7 (25.0) 10 (28.6) 0.604 
Td / Pi / Aa / Fn 11 (12.1) 2 (8.3) 2 (7.1) 5 (14.3) 0.785 
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Table 18: Correlation between smoking and the presence of suspected 
periodontopathogens  
Bacterial species YES n/9 (%) NO n/175 (%) p value 
Pg 3 (33.3) 51 (29.14) 0.518 
Td 1 (11.1) 44 (25.1) 0.307 
Pi 7 (77.8) 129(73.7) 0.570 
Aa 4(44.4) 79(45.1) 0.621 
Fn 9 (100.0) 149 (85.1) 0.246 
Pg / Td 1 (11.1) 26 (14.85) 0.612 
Pg / Pi 3 (33.3) 42 (24.0) 0.388 
Pg / Aa 1 (11.1) 26 (14.85) 0.606 
Pg / Fn 3 (33.3) 39 (22.28) 0.341 
Td / Pi 1 (11.1) 41 (23.4) 0.349 
Td / Aa 1 (11.1) 23 (13.1) 0.668 
Td / Fn 1 (11.1) 39 (22.3) 0.380 
Pi  / Aa 2 (22.2) 61 (34.9) 0.350 
Pi / Fn 7 (77.8) 111 (63.4) 0.312 
Aa / Fn 4(44.4) 72 (41.1) 0.552 
Pg / Td / Pi 1 (11.1) 25 (14.3) 0.629 
Pg / Td / Aa 1 (11.1) 26 (14.9) 0.609 
Pg / Td / Fn 1 (11.1) 22 (12.6) 0.687 
Pg / Pi / Aa 1 (11.1) 23 (13.1) 0.668 
Pg / Pi / Fn 3 (33.3) 33 (18.9) 0.247 
Pg / Aa / Fn 1 (11.1) 22 (12.6) 0.687 
Td / Pi / Aa 1 (11.1) 22 (12.6) 0.687 
Td / Pi / Fn 1 (11.1) 36 (20.6) 0.428 
Pi / Aa / Fn 1 (11.1) 55 (31.4) 0.433 
Td / Pi / Aa / Fn 1 (11.1) 21 (12.0) 0.707 
 
4.7. CORRELATION BETWEEN CLINICAL SIGNS OF GINGIVAL INFLAMMATION 
AND THE FIVE PERIODONTOPATHOGENS  
 
The only periodontopathogen which appeared to be significantly associated with patients 
showing clinical signs of gingival inflammation was P. intermedia, whether alone (p = 
0.013) or with another species viz Pg / Pi and Pi / Fn (p = 0.040 and 0.043 respectively).  
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P. gingivalis was closely but not significantly associated (p = 0.050). Combinations of three, 
four and five showed no association with clinical signs of gingival inflammation (Table 19). 
 
Table 19: Correlation between clinical signs of gingival inflammation and the presence 
of the five periodontopathogens 
Bacterial species No sign of gingival 
inflammation n/83 (%) 
Signs of gingival inflammation 
n/103 (%) 
p value 
Pg 18 (21.7) 35 (33.98) 0.050 
Td 17 (20.5) 28 (27.2) 0.187 
Pi 54 (65.1) 83 (80.6) 0.013 
Aa 42 (50.6) 40 (38.8) 0.072 
Fn 71 (85.5) 89 (86.4) 0.515 
Pg / Td 12 (14.5) 14 (13.59) 0.504 
Pg / Pi 14 (16.86) 30 (29.1) 0.040 
Pg / Aa 10 (12.04) 16 (15.5) 0.333 
Pg / Fn 15 (18.3) 26 (25.2) 0.171 
Td / Pi 16 (19.3) 26 (25.2) 0.215 
Td / Aa 12 (14.5) 11 (10.7) 0.289 
Td / Fn 15 (18.1) 25 (24.3) 0.200 
Pi  / Aa 30 (36.1) 32 (31.1) 0.283 
Pi / Fn 47 (56.6) 72 (69.9) 0.043 
Aa / Fn 38 (45.8) 37 (35.9) 0.113 
Pg / Td / Pi 12 (14.5) 13 (12.6) 0.439 
Pg / Td / Aa 12 (14.5) 14 (13.6) 0.515 
Pg / Td / Fn 10 (12.0) 12 (11.7) 0.555 
Pg / Pi / Aa 9 (10.8) 14 (13.6) 0.369 
Pg / Pi / Fn 12 (14.5) 23 (22.3) 0.119 
Pg / Aa / Fn 9 (10.8) 13 (12.6) 0.445 
Td / Pi / Aa 12 (14.5) 10 (9.7) 0.221 
Td / Pi / Fn 14 (16.9) 23 (22.3) 0.229 
Pi / Aa / Fn 27 (32.5) 29 (28.2) 0.313 
Td / Pi / Aa / Fn 11 (13.3) 10 (9.7) 0.298 
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4.8. CORRELATION BETWEEN THE FIVE PERIODONTOPATHOGENS AND 
PREGNANCY OUTCOMES 
 
No significant association was observed between the presence of the five 
periodontopathogens and preterm delivery of low birth weight infants (Table 20). 
 
Table 20: Correlation between the presence of the five periodontopathogens and 
pregnancy outcomes 
Bacterial species Normal Birth n/98 (%) PLBW n/91 (%) p value 
Pg 28 (28.57) 26 (28.6) 0.546 
Td 22 (22.4) 24 (26.4) 0.323 
Pi 69 (70.4) 70 (76.9) 0.198 
Aa 48 (49.0) 37 (40.7) 0.158 
Fn 82 (83.7) 81 (89.0) 0.197 
Pg / Td 14 (14.28) 13 (14.3) 0.570 
Pg / Pi 23 (23.46) 22 (24.2) 0.538 
Pg / Aa 15 (15.30) 12 (13.2) 0.407 
Pg / Fn 22 (22.4) 20 (22.0) 0.524 
Td / Pi 21 (21.4) 22 (24.2) 0.391 
Td / Aa 11 (11.2) 13 (14.3) 0.340 
Td / Fn 19 (19.4) 22 (24.2) 0.267 
Pi  / Aa 36 (36.7) 28 (30.8) 0.238 
Pi / Fn 59 (60.2) 62 (68.1) 0.163 
Aa / Fn 45 (45.9) 33 (36.3) 0.115 
Pg / Td / Pi 14 (14.3) 12 (13.2) 0.498 
Pg / Td / Aa 14 (14.3) 13 (14.3) 0.582 
Pg / Td / Fn 12 (12.2) 11 (12.1) 0.576 
Pg / Pi / Aa 14 (14.3) 10 (11.0) 0.323 
Pg / Pi / Fn 20 (20.4) 16 (17.6) 0.379 
Pg / Aa / Fn 14 (14.3) 9 (9.9) 0.242 
Td / Pi / Aa 11 (11.2) 12 (13.2) 0.424 
Td / Pi / Fn 18 (18.4) 20 (22.0) 0.331 
Pi / Aa / Fn 33 (33.7) 25 (27.5) 0.222 
Td / Pi / Aa / Fn 11 (11.2) 11 (12.1) 0.516 
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4.9. DISCUSSION 
 
The objective of this chapter was to examine an African population for the presence of 
anaerobic bacteria frequently associated with periodontal disease and implicated in adverse 
pregnancy outcomes such as PLBW. We elected to use gingival crevicular fluid instead of 
dental plaque because it enabled us to use the same sample to examine for bacterial species 
(using PCR) as well as for inflammatory cytokines (next chapter) which may serve as 
biomarkers for preterm delivery.  
 
One sample was collected from each quadrant of the mouth and the four samples pooled to 
yield a single sample for each patient (Kim et al, 2007). PCR was used to detect five 
suspected periodontopathogens and the PCR results matched with selected risk factors (age, 
level of education, smoking, alcohol consumption, oral health care) and indicators (bleeding 
when brushing, gingival inflammation) for periodontal disease. In the absence of adequate 
diagnosis of periodontal disease, we concede that the associations may be inconclusive and 
for that reason, we present these results as an association between proposed risk factors for 
periodontal disease and PLBW rather than the presence of periodontal disease and PLBW. 
Although the five anaerobic bacteria examined for in this study have been implicated in 
PLBW, no overt association exists. 
 
Significant associations were observed between the level of education and the presence of T. 
denticola and its combinations with other bacteria. The patients with no formal education 
and those who attended University were more likely to harbour the two bacteria and its 
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combinations with other bacteria. With the exception of P intermedia which showed a 
significant association with clinical signs of gingival inflammation (p = 0.013) and also with 
the frequency of tooth brushing (p = 0.045), none of the other species could be significantly 
associated with age, smoking, alcohol consumption, frequency of brushing, pain and 
bleeding when brushing,  nor gingival inflammation when detected on their own. Bacterial 
combinations however, yielded significant correlations especially when Aa and P. 
intermedia were present. Gingival bleeding when brushing was the only variable where T. 
denticola showed any association, particularly when detected along with P. gingivalis. 
Because anaerobic spirochaetes are known indicators of periodontal disease (Loesche et al., 
1988), one may speculate that these patients reporting bleeding when brushing their teeth 
had, or were at risk for, periodontal disease. 
 
The association with gingival inflammation supports the positive correlation reported by 
other researchers between poor periodontal health and PLBW (Madianos et al., 2001; 
Dörtbudak et al., 2005; Jarjoura et al., 2005; Bosnajak et al., 2006; Lin et al., 2007). 
However, our dichotomous recording of “presence” or “absence” of gingival inflammation 
as opposed to the use of periodontal indices as a measurement of periodontal health or 
disease provides a rather crude assessment of the periodontal health of the mother and thus 
caution should be exercised in interpretation of this finding.  
 
In those studies where differences in the presence of the five bacteria were reported when 
comparing NT and PLBW, the results yielded no statistical significance between the groups 
when bacterial load was taken into account (Papapanou et al., 2000; Noack et al., 2005; 
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Skuldbol et al., 2006) and therefore, as in our study, failed to establish a direct association 
between these species and PLBW. It could be interpreted that the detection of all five 
species in both cases and controls, may suggest a “carrier” state for all of these species. 
However, the lack of quantification of bacterial load, in all of the samples, presents an 
obstacle in drawing a finite conclusion. 
 
In general, P. intermedia showed significant associations either singly or in combinations 
with most indicators of periodontal disease used in this study (gum bleeding, frequency of 
tooth brushing and clinical signs of gingival inflammation). Aa and members of the “Red 
Complex” were significantly associated with gum bleeding and frequency of tooth brushing 
only.  
 
The consistent finding of Aa in all the bacterial combinations which showed a significant 
correlation with the variables described deserves some discussion. Aa has been significantly 
associated with aggressive periodontitis (Imbronito et al., 2008). It has also frequently been 
found in healthy individuals (Buduneli et al., 2005). Studies of different population groups 
have revealed that a unique Aa clone (JP2) is responsible for the aggressive form of 
periodontitis observed in adolescents from north and west Africa (Haubek et al., 1997, 
2008) and from individuals of African origin living in Europe and USA. Being an Africa 
population, the prevalence of Aa in these subjects is not surprising.  
 
It could be argued that the presence of Aa is nothing more than an indicator of a “Carrier” 
state, but the increased significance of the associations of the bacteria in combination with 
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the variables described, would suggest otherwise. All of the combinations significantly 
associated with gingival bleeding when brushing include Aa. It has been suggested that Aa 
may occur in 2 forms, either as an opportunistic pathogen occurring world-wide with a 
diversity of Aa clones or as an exogenous pathogen with a particular clone (JP2) racially 
restricted to persons of African origin (Haubek et al., 1997). Further studies on this 
population group are underway and will inform us of the actual role played by Aa in this 
population and therefore in PLBW. 
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CHAPTER 5: EVALUATION OF IL-6 AND IL-10 LEVELS IN  
                           MATERNAL AND FOETAL CORD SAMPLES 
 
5.1. INTRODUCTION 
 
Cytokines are soluble proteins and peptides that act as humoral regulators at nano to 
picomolar concentration and which, either under normal or pathological conditions, 
modulate the functional activities of individual cells and tissues. Cytokines also mediate 
interaction between cells directly and regulate processes in the extracellular environment. 
Some cytokines behave like classical hormones in that they are involved in biological 
phenomena such as inflammation, systemic inflammatory response syndrome, and acute 
phase reaction, wound healing, and the neuroimmune network. Unlike hormones, cytokines 
are not produced by specialized cells organized in specialized glands and act on a wider 
range of target cells than hormones (Saini and Arora, 2011). The different types of cytokines 
include interleukins that were first seen to be produced by white cells (leucocytes), 
lymphokines, initially thought to be produced by lymphocytes; monokines, initially thought 
to be produced by monocytes; interferons, initially thought to participate in antiviral 
responses; colony stimulating factors CSF), initially thought to help the growth of cells and 
chemokines and thought to participate in chemotaxis (Saini and Arora, 2011). 
 
T helper cells, also known as Th cells are a sub-group of lymphocytes that play an important 
role in establishing and maximizing the capacity of the immune system. Type 1 cytokines 
are those produced by Th1 T-helper cells and include IL-2, IL-6, IL-12, IFN-gamma and 
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TNF-β, while type 2 cytokines are produced by Th2 T-helper cells and include IL-4, IL-5, 
IL-10 and IL-13. Th1-type cytokines produce the proinflammatory response which helps the 
killing of intracellular parasites and perpetuate the autoimmune responses. Th2 cytokines 
tend to produce an anti-inflammatory response and counteract the excessive 
proinflammatory responses which can lead to uncontrolled tissue damage.  
 
The human immune system should produce a well balanced Th1 and Th2 response (Jarocki 
et al., 2007). Maternal Th1 cells that mediate allospecific cytotoxic responses are inhibited 
during pregnancy to prevent rejection of the fetal allograft, while Th2 cells which mediate 
antibody responses are increased to prevent complete immunosuppression (Warning et al., 
2011). Earlier studies found that the host immune response could be a causative factor in the 
induction of preterm labor. Accumulation of pro-inflammatory cytokines by the host 
response can induce the release of substances like prostaglandin from gestational tissues  
that induce the uterus to contract and cause preterm labour. Elevated levels of inflammatory 
cytokines were found in women with preterm labour (Casey and MacDonald, 1988; Romero 
et al., 1988; Jarocki et al., 2007). Previous research showed that IL-6 and IL-10 have 
opposed biological effects in preterm labour. IL-6 is an inflammatory cytokine which can 
cause the release of prostaglandins and cause uterine contraction while IL-10 (anti 
inflammatory cytokine) is a body regulator of the inflammatory cytokine pathway (Jarocki 
et al., 2007; Perinatal Research Center, 2009).  
 
Among the different mechanisms postulated by which periodontal disease may trigger 
PLBW, are the increased levels of cytokines in plasma of patients with periodontal disease 
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which may cross foetal membranes (Offenbacher et al. (1998a). The presence of suspected 
periodontopathogens in GCF of these mothers, would elicit a host response to the antigens 
presented. One of the objectives of this study was to evaluate IL-6, and IL-10 levels in blood 
serum samples from the mother and foetal cords in PLBW and normal birth.  
 
The evaluation of IL-10 and IL-6 levels in blood serum from the mother and foetal cords 
was done by ELISA as explained in the material and methods chapter of this study. In this 
chapter, the following abbreviations will be used: MB: Maternal blood and FCB: Foetal 
Cord Blood 
 
5.2. IL-10 AND IL-6 RESULTS 
 
The means (standard error of the mean) were: 47.32 pg/ml (± 6.526), 21.26 (± 4.413), 46.19 
(± 5.517), 67.49 (± 9.482) respectively for IL-10 MB, IL-10 FCB, IL-6 MB and IL-6 FCB. 
Minimum and maximum were   -2.521 and 813.8, -22.05 and 443.4, 0.327 and 665.2, -3.168 
and 826.2 also respectively for IL-10 MB, IL-10 FCB, IL-6 MB and IL-6 FCB (Table 21).  
 
 
 
 
 
  
 
 
 
 
 70
Table 21: Descriptive statistics of IL-10 and IL-6 results 
 Minimum Maximum Mean Standard deviation Standard Error 
IL-10 MB (pg/ml) -2.521 813.8 47.32 91.83 6.526 
IL-10 FCB (pg/ml) -22.05 443.4 21.26 62.09 4.413 
IL-6 MB (pg/ml) 0.327 665.2 46.19 77.64 5.517 
IL-6 FCB (pg/ml) -3.168 826.2 67.49 133.1 9.482 
 
When examining the association between maternal medical records and IL-10 and IL-6 
(Table 22), a significant association was observed between IL-6 MB and age (p = 0.018). 
The level of IL-6 MB for patients > 36 years was very low (72.93 pg/ml) compared with 
other age groups. IL-10 levels in FCB showed a significant association with maternal weight 
(p = 0.024) with mothers weighing ≤ 60 kg more likely to have a higher level of IL-10 than 
those weighing > 60 kg. The p values were 0.021 and 0.008 respectively for IL-10 MB and 
IL-10 FCB in these two groups. Also, the levels of IL-6 were higher in patients weighing ≤ 
60 kg than in patients weighing > 60 kg but the differences were not significant (Table 22). 
Significant associations were also observed between the height of the mother and IL-10 and 
IL-6 results. Elevated levels  of IL-10 MB, IL-10 FCB and IL-6 MB were associated with 
short rather than tall mothers (p = 0.002, 0.020 and 0.048 respectively) while levels of 
education could not be associated with IL-10 and IL-6 in this study (Table 22).  
 
Higher levels of IL-10 FCB were observed when mothers reported being in their first 
pregnancy than those who reported multiple pregnancies (p = 0.040). Also the level of IL-6 
was generally higher for mothers in their first pregnancy than those with multiple 
pregnancies but the difference was not significant (Table 22). However, no significant 
association was observed between mothers with induced abortion and IL-10 and IL-6 results 
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(Table 22). Previous preterm deliveries resulted in the expression of a higher level of IL-10 
FCB than when mothers had no history of previous preterm deliveries (Table 22). 
 
No significant associations were observed between IL-10 and IL-6 and maternal history of 
urinary tract infection, STD and heart disease (Table 22). Neither were any significant 
associations observed between IL-10/IL-6 and gum bleeding, pain while brushing, 
frequency of tooth brushing, access to medical aid and alcohol consumption of the mothers 
(Table 23), although a significant association (p = 0.032) was observed  between smokers 
and IL-6 MB, (p = 0.032) (Table 23). There was also a significant association (p = 0.036) 
between antibiotic administration and IL-6 MB. Patients who took antibiotics before 
delivery had a lower level of IL-6 MB (82.82 pg/ml) than those who didn’t (Table 23). No 
significant differences were observed between clinical signs of gingival inflammation as 
observed by the clinician, and the levels of IL-10 and IL-6 (Table 23). 
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Table 22: Association between maternal medical history and  IL-10 and IL-6  
  
n 
IL-10 MB 
mean pg/ml 
IL-10 FCB 
mean pg/ml 
IL-6 MB 
mean pg/ml 
IL-6 FCB 
mean pg/ml 
AGE (years)   
< 20  
20 – 25  
26 – 30  
31 – 35  
≥ 36 
p value 
17 
57 
58 
37 
23 
94.00 
108.67 
108.67 
83.53 
105.09 
0.192 
120.50 
99.05 
88.47 
93.81 
97.00 
0.332 
109.35 
111.42 
84.74 
100.69 
72.93 
0.018 
96.47 
97.57 
86.47 
107.14 
97.95 
0.509 
WEIGHT (kg)   
≤ 50 
51 – 55  
56 – 60  
61 – 65  
> 65  
p value 
16 
34 
44 
38 
53 
110.06 
103.63 
97.65 
90.74 
78.79 
0.131 
90.34 
112.69 
100.69 
91.96 
75.53 
0.024 
69.22 
106.37 
99.08 
88.88 
89.51 
0.178 
88.69 
105.37 
96.56 
87.74 
85.31 
0.467 
WEIGHT (kg)   
≤60  
> 60  
p value 
94 
91 
101.93 
83.78 
0.021 
103.27 
82.39 
0.008 
96.63 
89.25 
0.348 
98.40 
86.33 
0.124 
HEIGHT (cm)   
≤ 50  
151 – 155  
156 – 160   
160 – 165  
> 165  
p value 
30 
40 
43 
38 
30 
115.15 
99.08 
89.07 
88.51 
62.00 
0.002 
110.13 
95.29 
90.37 
92.55 
65.08 
0.020 
107.60 
105.04 
82.20 
81.57 
80.25 
0.048 
105.92 
86.05 
88.76 
84.24 
91.48 
0.474 
LEVEL OF 
EDUCATION 
  
No formal education 
Primary school 
High School 
university 
p value 
17 
120 
42 
15 
127.32 
97.54 
85.14 
97.97 
0.077 
108.26 
99.44 
93.96 
79.70 
0.486 
116.76 
98.90 
90.13 
85.13 
0.317 
109.18 
102.06 
86.58 
72.20 
0.102 
NUMBER OF 
PREGNANCIES 
  
First 
Multiple 
p value 
74 
118 
95.57 
97.08 
0.855 
106.89 
89.99 
0.040 
106.38 
90.31 
0.051 
97.91 
94.79 
0.704 
INDUCED 
ABORTION 
  
Yes 
No 
p value 
33 
103 
77.65 
65.57 
0.125 
71.79 
67.45 
0.582 
61.36 
70.79 
0.232 
74.92 
65.76 
0.242 
PREVIOUS 
PRETERM 
DELIVERIES 
  
Yes 
No 
p value 
31 
100 
71.69 
64.24 
0.339 
81.84 
61.09 
0.008 
66.66 
65.80 
0.912 
74.71 
62.62 
0.119 
URINARY TRACT 
INFECTION 
  
Yes 
No 
p value 
44 
114 
89.02 
96.17 
0.446 
91.77 
95.33 
0.704 
93.85 
94.70 
0.928 
102.18 
91.48 
0.252 
STD   
Yes  
No 
p value 
26 
166 
81.67 
98.82 
0.143 
89.81 
97.55 
0.509 
97.15 
96.40 
0.949 
111.87 
93.50 
0.115 
HISTORY OF 
HEART DISEASE 
  
Yes 
No 
p value 
19 
173 
107.97 
95.24 
0.343 
102.08 
95.89 
0.645 
101.92 
95.90 
0.654 
108.84 
94.58 
0.286 
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Table 23: Association between maternal smoking, alcohol consumption and oral health 
care and  IL-10 and IL-6  
CHARACTERISTICS  
n 
IL-10 MB 
mean pg/ml 
IL-10 FCB 
mean pg/ml 
IL-6 MB 
mean pg/ml 
IL-6 FCB 
mean pg/ml 
FREQUENCY OF TOOTH 
BRUSHING 
  
Once a day 
Twice a day 
After every meal 
p value 
91 
57 
5 
74.71 
80.53 
78.50 
0.737 
73.22 
84.39 
61.60 
0.241 
78.11 
75.96 
68.60 
0.875 
73.66 
81.04 
75.80 
0.612 
BLEEDING WHILE BRUSHING   
Yes 
No 
p value 
99 
61 
80.12 
81.12 
0.894 
81.09 
79.55 
0.839 
99(80.89 
79.87 
0.892 
81.51 
77.57 
0.600 
PAIN WHILE BRUSHING   
Yes 
No 
p value 
40 
111 
70.79 
77.88 
0.379 
73.18 
77.02 
0.634 
81.53 
74.01 
0.351 
76.65 
75.08 
0.845 
ACCESS TO MEDICAL AID   
Yes 
No 
p value 
33 
159 
105.56 
94.62 
0.303 
95.68 
96.67 
0.926 
95.27 
96.75 
0.889 
103.76 
94.38 
0.375 
ALCOHOL CONSUMPTION    
Never  
Daily 
Weekly 
Special occasions 
p value 
96 
23 
29 
37 
90.62 
105.15 
85.59 
97.43 
0.535 
92.15 
104.30 
82.00 
96.80 
0.483 
95.32 
90.07 
100.45 
82.97 
0.550 
87.12 
107.07 
99.28 
91.95 
0.367 
SMOKING   
Yes 
No 
p value 
8 
184 
115.19 
95.69 
0.331 
64.75 
97.88 
0.099 
137.63 
94.71 
0.032 
98.00 
95.91 
0.917 
ANTIBIOTIC 
ADMINISTRATION 
  
Yes 
No 
p value 
55 
136 
91.76 
97.71 
0.501 
90.25 
98.33 
0.360 
82.82 
101.33 
0.036 
87.26 
98.86 
0.188 
GINGIVAL INFLAMMATION 
AND BLEEDING 
  
Yes 
No 
p value 
83 
103 
90.15 
96.20 
0.446 
88.00 
97.93 
0.211 
89.41 
96.80 
0.352 
89.18 
96.11 
0.382 
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Table 24: Association between periodontopathogens and IL-10 and IL-6  
Bacterial species  
 
IL-10 MB 
mean pg/ml 
IL-10 FCB 
mean pg/ml 
IL-6 MB 
mean pg/ml 
IL-6 FCB 
mean pg/ml 
 n/187  
P. gingivalis 
p value 
54 87.45 
0.292 
86.29 
0.214 
98.44 
0.474 
91.23 
0.713 
 n/186  
T. denticola 
p value 
46 97.57 
0.555 
98.35 
0.481 
97.41 
0.570 
91.76 
0.856 
 n/186  
P. intermedia 
p value 
 95.68 
0.363 
95.28 
0.458 
99.19 
0.017 
93.87 
0.718 
 n/186  
A. actinomycemcomitans 
p value 
85 96.62 
0.469 
93.65 
0.973 
94.20 
0.871 
92.59 
0.923 
 n/186  
F. nucleatum 
p value 
160 94.62 
0.482 
94.78 
0.420 
93.30 
0.900 
96.32 
0.037 
 
 
Table 24 shows the association between the five periodontopathogens and the levels of IL-
10 and IL-6. Only P. intermedia showed a significant association with IL-6 MB (p = 0.017) 
and F. nucleatum with IL-6 FCB (p = 0.037).  
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Table 25: Association between paired combinations of periodontopathogens and IL-10 
and IL-6  
Bacterial species  
 
IL-10 MB 
mean pg/ml 
IL-10 FCB 
mean pg/ml 
IL-6 MB 
mean pg/ml 
IL-6 FCB 
mean pg/ml 
 n/187  
Pg / Td 
p value 
27 99.35 
0.579 
96.70 
0.779 
109.50 
0.108 
91.56 
0.839 
 n/185  
Pg / Pi 
p value 
45 84.57 
0.225 
82.88 
0.145 
97.46 
0.521 
83.49 
0.192 
 n/185  
Pg / Aa 
p value 
27 83.33 
0.310 
91.31 
0.860 
97.20 
0.659 
94.74 
0.813 
 n/185  
Pg / Fn 
p value 
42 84.27 
0.230 
82.82 
0.161 
97.56 
0.530 
93.67 
0.872 
 n/186  
Td / Pi 
p value 
43 99.92 
0.373 
98.08 
0.525 
97.67 
0.562 
92.47 
0.940 
 n/186  
Td / Aa 
p value 
24 98.81 
0.604 
99.52 
0.557 
99.90 
0.533 
94.58 
0.877 
 n/186  
Td / Fn 
p value 
41 96.65 
0.672 
94.12 
0.933 
97.32 
0.607 
95.59 
0.726 
 n/186  
Pi  / Aa 
p value 
64 92.23 
0.816 
91.20 
0.672 
99.25 
0.291 
88.30 
0.385 
 n/186  
Pi / Fn 
p value 
118 96.62 
0.297 
96.10 
0.385 
99.44 
0.047 
97.09 
0.173 
 n/186  
Aa / Fn 
p value 
78 96.42 
0.529 
93.47 
0.996 
94.82 
0.776 
93.09 
0.984 
 
 
 
When the five periodontopathogens were detected in pairs, only Pi / Fn showed a significant 
association with the level of IL-6 MB (Table 25) (p = 0.047).  
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Table 26: Association between combinations of three or more periodontopathogens 
and IL-10 and IL-6 results 
Bacterial species n/186 
 
IL-10 MB 
mean pg/ml 
IL-10 FCB 
mean pg/ml 
IL-6 MB 
mean pg/ml 
IL-6 FCB 
mean pg/ml 
Pg / Td / Pi 
p value 
26 98.71 
0.595 
94.00 
0.959 
107.79 
0.145 
89.19 
0.696 
Pg / Td / Aa 
p value 
27 99.17 
0.554 
96.41 
0.762 
108.69 
0.113 
91.33 
0.861 
Pg / Td / Fn 
p value 
23 98.46 
0.637 
91.26 
0.831 
111.50 
0.087 
96.30 
0.752 
Pg / Pi / Aa 
p value 
24 80.42 
0.202 
88.13 
0.600 
100.10 
0.520 
90.79 
0.829 
Pg / Pi / Fn 
p value 
36 83.49 
0.214 
79.89 
0.091 
99.15 
0.483 
87.03 
0.456 
Pg / Aa / Fn 
p value 
23 83.41 
0.337 
88.11 
0.608 
98.80 
0.614 
96.87 
0.711 
Td / Pi / Aa 
p value 
23 98.28 
0.649 
96.93 
0.744 
98.50 
0.634 
92.30 
0.947 
Td / Pi / Fn 
p value 
38 99.24 
0.461 
93.49 
0.999 
97.61 
0.598 
96.68 
0.634 
Pi / Aa / Fn 
p value 
58 91.82 
0.774 
91.22 
0.697 
99.24 
0.328 
88.62 
0.452 
Td / Pi / Aa / Fn 
p value 
22 98.86 
0.619 
95.20 
0.874 
100.98 
0.488 
90.77 
0.835 
 
 
No significant association was observed with levels of IL-10 and IL-6 and the detection of 
five periodontopathogens in combinations of 3 and more (Tables 26). A strong association 
between PLBW and the levels of IL-10 MB, IL-10 FCB and IL-6 FCB (p = 0.002, 0.000 and 
0.000 respectively) was observed (Table 26).  
 
 
Table 27a: Association between pregnancy outcomes and IL-10 and IL-6 results 
 
 
PLBW NORMAL  
Number Mean pg/ml Number Mean pg/ml p value 
IL-10 MB 
(pg/ml) 
97 111.78 100 86.60 0.002 
IL-10 FCB 
(pg/ml) 
97 122.83 100 75.89 0.000 
IL-6 MB 
(pg/ml) 
97 93.89 100 103.96 0.215 
IL-6 FCB 
(pg/ml) 
97 116.30 99 81.06 0.000 
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Table 27b: Correlation between cytokines ratios (IL-6M/ IL-10M and IL-6M/ IL-10M) 
with the 5 periodontopathogens, gingival inflammation and PLBW 
 IL-6M/IL-10M IL-6F/IL-10F 
T. denticola r 
p 
n 
0.054 
0.464 
186 
0.117 
0.113 
185 
P. gingivalis r 
p 
n 
0.091 
0.216 
187 
0.006 
0.935 
186 
P. intermedia r 
p 
n 
0.143 
0.051 
186 
0.104 
0.159 
185 
A. actinomycetemcomutans r 
p 
n 
0.033 
0.656 
186 
-0.091 
0.217 
186 
F. nucleatum r 
p 
n 
-0.036 
0.628 
186 
-0.000 
0.997 
185 
Gingival inflammation r 
p 
n 
0.061 
0.406 
186 
-0.018 
0.804 
186 
PLBW r 
p 
n 
0.088 
0.220 
197 
-0.016 
0.824 
196 
r = coefficient of correlation, p = p value, n = number of patients 
 
IL-10 MB, IL-10 FCB and IL-6 FCB were significantly associated with PLBW. No 
significant association was found between PLBW and IL-6 MB (Table 27a). No correlation 
was found between the ratio of the two cytokines (IL-6 and IL-10) in maternal blood or in 
foetal cord blood with the 5 periodontopathogens, gingival inflammation nor PLBW (Table 
27b). 
 
5.3. DISCUSSION  
 
The objective of this chapter was to evaluate the relationship between PLBW, Interleukin- 6, 
Interleukin - 10 and the presence of periodontopathogens. For this purpose, maternal and 
foetal cord blood samples were collected for the evaluation of IL-6 and IL-10 levels using 
the ELISA test as these two cytokines were found to play an important role in PLBW. 
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Age, level of education, urinary tract infections, STD, history of heart disease, gum 
bleeding, pain while brushing, frequency of tooth brushing, signs of gingival inflammation, 
access to medical aid, and alcohol consumption may influence the levels of IL-6 and IL-10 
directly through infection or indirectly by contributing to the occurrence of an infection. All 
the above factors didn’t show any association with IL-6 and IL-10 in this study. The lack of 
association between signs of gingival inflammation and the levels of IL-6 and IL-10 in this 
study is unclear, and may be attributed to the coarse assessment of gingival inflammation in 
the absence of accurate measurement of clinical indices or radiographs. 
 
Mello et al., (2008), in their study on the effect of weight-loss on cytokines, found that 
weight reduction resulted in an increased expression of IL-6. In this study maternal weight 
appeared to be significantly associated with IL-10 and IL-6. This could be associated with 
malnutrition of the mothers which may increase the risk for of infection and therefore 
increase the production of inflammatory cytokines. Little is known about the history of 
previous preterm deliveries and number of previous pregnancies and cytokine levels. In our 
study, a significant association was demonstrated between number of pregnancies and IL-10 
FCB, while mothers with previous preterm deliveries had a higher level of IL-10 FCB.  
 
Smoking is strongly associated with periodontal disease and poor response to periodontal 
therapy. Also the upregulation of LPS-mediated monocyte secretion of PGE2 by nicotine 
may play an important role in the pathogenesis of periodontal disease (Haber and Kent; 
1992; Crossi et al., 1994; Payne et al., 1996; Kamma et al., 1999). In this study, smokers 
had a higher level of IL-6 MB than non-smokers (p = 0.032), and this significant finding is 
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in agreement with a study by Giannopoulou et al. (2003) who found that IL-6 levels 
significantly correlated with smoking.  
 
Antimicrobial agents have been reported to be involved both in vivo and in vitro in the 
modification of the inflammatory and the immune response (Morikawa et al., 1996). There 
was a significant association (p = 0.036) between antibiotic administration and IL-6 MB in 
this study. Patients who took antibiotics before delivery had a lower level of IL-6 MB (82.82 
pg/ml) than those who didn’t (101.33 pg/ml). This may be due to eradication of bacteria by 
antibiotics as described in a study by Morikawa et al., (1996) who found that 
dexamethasone deeply suppressed the synthesis of IL-6 and IL-10, fosfomycin enhanced the 
synthesis of both cytokines while clarithromycin enhanced only IL-10.  
 
Earlier studies on IL-10 levels differ. Some found a higher level of IL-10 in mothers with 
PLBW (Apuzzio et al., 2004), while others found low levels of IL-10 in mothers with 
PLBW (Greig et al., 1995; Lin et al., 2003; Jarocki et al., 2007). In the present study a 
strong association between PLBW and maternal and foetal cord serum sample levels of IL-
10 was observed (p = 0.002 and 0.000 for IL-10 MB and IL-10 FCB respectively). High 
maternal and foetal cord blood levels of IL-10 were found in PLBW. Many contradictions 
are reported in the literature regarding the role of IL-10 in PLBW and its role at the maternal 
– foetal interface remains controversial (Blidane and Stamatini 2002, Thaxton et al 2010).  
Some researchers reported a reduced level of IL-10 in PLBW (Dudley 1997, Bayouni et al 
2003) and CIPD (Yamakazi et al 2001, Gautoudi et al 2004), while others reported elevated 
levels of IL-10 with PLBW (Matoba et al 2009). The elevated IL-10 levels  in MB and FCB 
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may be due to the fact that the inflammatory responses are of foetal origin and may play a 
role in pregnancy loss. A recent study demonstrated that in women with pregnancy loss, 
some polymorphisms of IL-10 gene promoter could contribute as risk factors for PLBW 
(Cochery-Nouvellon et al., 2009). Menon et al., (2010) found that genetic regulation of 
cytokine concentrations in PTB differ with ethnicity and that cytokine concentrations were 
associated with interactions between genotype and PTB in African Americans, but not in 
Caucasians. 
 
Previous studies conducted to determine IL-6 levels in amniotic fluid of patients who 
presented with PLBW found that IL-6 could be a marker for PLBW (Apuzzio et al., 2004; 
Figueroa et al., 2005; Jarocki et al., 2007). A good association was observed between 
PLBW and FCB sample levels of IL-6 in this study. However no significant association was 
found in this study between PLBW and maternal blood levels of IL-6. The higher level of 
IL-10 in maternal blood found in this study could have an inhibitory effect on IL-6 thus 
decreasing its bioavailabilty. Previous studies also found that IL-6, TNF and IL-8 were 
regulated at the transcriptional level by IL-10 thus decreasing their bioavailability for action 
(Fortunate et al., 1996; 1997, 1998). 
 
It was suggested that cytokines may be used as markers in the diagnosis of the pathogenesis 
of periodontal disease (Giannopoulou et al., 2003). In this study only P. intermedia and F. 
nucleactum showed a significant association with IL-6. In both cases, patients with P. 
intermedia and F. nucleatum had higher maternal serum levels of IL-6 and foetal cord serum 
levels of IL-6 respectively. An association between P. gingivalis and IL-6 has been reported 
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previously (Hirose et al., 1997; Lin et al., 2003) and to our knowledge, this is the first 
human study showing the relationship between different periodontopathogens, maternal 
serum and feotal cord serum levels of IL-6 and IL-10. The relationship between pro- and 
anti –inflammatory cytokines and pregnancy outcomes could not be clearly established in 
this study, because F. nucleatum showed a significant correlation with IL-6 levels in FCB 
and when present with P.intermedia, a correlation with IL-6 was also observed in MB. P. 
intermedia and F. nucleatum are both associated with pregnancy gingivitis which may add 
to the oral inflammatory burden, thus increasing the risk for PTL. It was unexpected to find 
no correlation between IL-6 and IL-10 and gingival inflammation in this study. Studies by 
Skuldbol et al (2006) and Mitchell-Lewis et al (2001) also found no association between 
PTL and CIPD. 
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CHAPTER 6: EVALUATION OF IgG AND IgM LEVEL AGAINST  
                            FIVE PERIODONTOPATHOGENS 
 
6.1. INTRODUCTION  
 
Antibodies (also called immunoglobulins or Ig) are proteins which can bind specifically to a 
wide range of antigens and give a response that is important in antimicrobial defense. 
Antibodies are important for the prevention and/or cure of infections (bacterial or viral). 
There are different types of immunoglobulins that react specifically with the antigen that 
induced their formation. Five immunoglobulin classes are defined on the basis of their heavy 
chain composition, namely, IgG, IgM, IgA, IgE and IgD. Their functions in the host 
immunity are different and their synthesis occurs at different stages during an 
immunological response to an infection (Kenneth, 2011). 
 
Immunoglobulin G (IgG) is a protein with a molecular weight of 150,000 daltons. It consists 
of two identical heavy (H) chains and two identical light (L) chains. The two L chains are 
connected to the H chain and the two H-chains are connected to one another by disulfide 
bridges giving the molecule a Y- shaped appearance. IgG is the most predominant 
immunoglobulin in the serum (75% of the total serum immunoglobulin). It can diffuse out of 
the blood stream into the extravascular spaces and its concentration in tissue fluid is high 
during inflammation. Predominantly, IgG antibodies are involved in the secondary immune 
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response. IgG is very effective in neutralizing bacterial exotoxins and viruses. It crosses the 
placenta and provides passive immunity to the foetus and infant for the first six months. Its 
small size and persistence in the serum of the mother facilitates its sharing with the foetus in 
utero, thus explaining why an infant is born with the full complement of the mother’s IgG 
(Kenneth, 2011).  
 
Immunoglobulin M (IgM) is the first Ig to be synthesized by infants and the first to appear in 
the blood stream when an infection occurs. IgM makes up around 10% of the total serum 
immunoglobulin. The most important role of IgM is its ability to function early in the 
immune response against blood-borne pathogens. It is very efficient in agglutinating 
particulate antigens. IgM binds to a microbe rendering the microbe more susceptible to 
phagocytosis. On the surface of mature B cells, IgM functions as an antigen receptor capable 
of activating B cells when bound to the antigen (Kenneth, 2011). 
 
Previous studies found that patients who presented with PLBW had an increased level of 
antibodies against certain periodontopathogens (Hill, 1998; Dasanayake et al. 2001, 2003; 
Dörtbudak et al., 2005) while other studies found the opposite (Madianos et al., 2001; 
Jarjoura et al., 2005; Lin et al., 2007). In the present study, the ELISA test was used to 
investigate the IgG and IgM levels in maternal and foetal cord blood samples respectively, 
directed against 5 suspected periodontopathic bacteria (Porphyromonas gingivalis, 
Treponema denticola, Prevotella intermedia, Fusobacterium nucleatum, Aggregatibacter  
actinomycetemcomitans) in order to establish the host immunological response of the mother 
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to these periodontal pathogens and their association with PLBW. The details of the 
methodology are outlined in chapter two.  
 
6.2. IgG AND IgM RESULTS 
 
The IgG or IgM levels were expressed in percentage compared to O.Ds of protein A (100 %) 
from Staphylococcus aureus which is an immunoglobulin binding substrate. In this chapter 
the following abbreviations were used: Pi-IgG = IgG against Prevotella intermedia, Pg-IgG 
= IgG against Porphyromonas gingivalis, Fn-IgG = IgG against Fusobacterium nucleatum, 
Aa-IgG = IgG against Aggregatibacter actinomycetemcomitans, Td-IgG = IgG against 
Treponema denticola, Pi-IgM = IgM against Prevotella intermedia, Pg-IgM = IgM against 
Porphyromonas gingivalis, Fn-IgM = IgM against Fusobacterium nucleatum, Aa-IgM = 
IgM against Aggregatibacter actinomycetemcomitans, Td-IgM = IgM against Treponema 
denticola. 
 
Only Aa-IgM showed a significant difference with maternal age (p = 0.008) and level of 
education (0.007) (Tables 28 and 29). The level of IgM against Aa in mothers aged < 20 
years and also in mothers with no formal education was very low compared with other 
groups. No significant differences were associated with IgG and IgM against the other 
periodontopathogens and age or the level of education (Tables 28 and 29), nor were any 
significant associations observed between oral health care and IgG and IgM levels (Tables 
28 and 29). Only Pg-IgG and Pi-IgM showed a significant association with maternal gum 
bleeding with p values of 0.013 and 0.029 respectively (Tables 28 and 29). Pg-IgG and Td-
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IgM showed a good correlation with maternal gingival pain during tooth brushing (p= 0.003 
and 0.002 respectively, Tables 28 and 29). No significant association was observed between 
smoking, alcohol consumption and IgG nor IgM except for Pg-IgM which showed an 
association with mothers who smoke (p = 0.045, Tables 28 and 29). PCR detection of A 
actinomycetemcomitans and P. gingivalis showed significant associations with their specific 
IgG (p = 0.012) and IgM (p = 0.011) levels respectively. No significant associations were 
observed between the other bacteria and their respective IgG or IgM levels (Tables 28 and 
29). 
 
Higher levels of specific IgG and IgM against different periodontopathogens were observed 
in mothers with gingival inflammation, with only Fn-IgG and Pg-IgM showing a significant 
association (p = 0.026 and p = 0.021 respectively). Mothers with no sign of gingival 
inflammation had higher levels of Fn-IgG with low levels of Pg-IgM in FCB. (Tables 28 
and 29).  Positive correlations between IgG levels and infection with P. gingivalis and Aa 
have been reported previously (Nakagawa et al., 1994).  
 
There was a significant association between PLBW and IgG against the different 
peridontopathogens with the following p values: 0.002, 0.002, 0.016, 0.000 and 0.023 
respectively for Pi-IgG, Pg-IgG, Fn-IgG, Aa-IgG and Td-IgG. Mothers with PLBW babies 
had a low level of IgG against the different periodontopathogens compared to those with 
normal babies. No significant associations were observed between PLBW and IgM against 
the 5 periodontopathogens although higher levels of IgM were observed in FCB with PLBW 
(Tables 28 and 29).  
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Table 30 shows the correlation between the level of cytokines (IL-6 and IL-10) in maternal 
blood and foetal cord blood, and the levels of IgG and IgM against the 5 
periodontopathogens. The following association showed a positive correlation: Pi-IgG with 
IL-6 FCB (p = 0.045), Aa-IgG with IL-10 FCB (p = 0.046) and Td-IgG with IL-6 MB (p = 
0.003) while the following showed negative correlations with IL-10 MB: Pi-IgM (p = 
0.044), Pg-IgM (p = 0.001) and Aa-IgM (p = 0.019). In general, most positive correlations 
were seen with IgG and negative correlations with IgM (Table 30).   
 
 
 
 
 87
Table 28: Association between IgG against periodontopathogens and maternal history 
Parameters n Pi-IgG 
(Median %) n 
Pg-IgG 
(Median %) n 
Fn-IgG 
(Median %) n 
Aa-IgG 
(Median %) n 
Td-IgG 
(Median %) 
Age in years: 
< 20 years 
21 - 25 
26 - 30 
31 - 35 
≥ 36 
p value 
 
17 
58 
58 
37 
23 
 
34.99 
37.03 
36.75 
37.13 
42.59 
0.772 
 
17 
58 
58 
37 
23 
 
42.41 
52.43 
51.14 
50.97 
46.62 
0.865 
 
17 
58 
58 
37 
23 
 
27.65 
36.30 
33.94 
24.30 
38.22 
0.552 
 
17 
58 
58 
37 
23 
 
30.84 
39.79 
42.36 
37.09 
36.73 
0.756 
 
17 
58 
58 
37 
23 
 
25.68 
25.89 
23.48 
14.59 
20.43 
0.212 
Education: 
No education 
Primary School 
High School 
University 
p value 
 
18 
119 
42 
15 
 
 
40.04 
37.11 
28.79 
46.33 
0.401 
 
18 
119 
42 
15 
 
 
36.60 
50.97 
45.82 
55.85 
0.587 
 
18 
119 
42 
15 
 
 
33.21 
36.21 
25.62 
29.19 
0.387 
 
18 
119 
42 
15 
 
 
33.86 
43.42 
25.95 
46.62 
0.331 
 
18 
119 
42 
15 
 
 
23.73 
25.07 
19.26 
29.04 
0.439 
Dentist Visit frequency: 
Never 
Once a year 
Twice a year 
When ever 
p value 
 
132 
42 
8 
4 
 
37.26 
31.55 
33.17 
28.39 
0.891 
 
132 
42 
8 
4 
 
47.22 
50.09 
45.65 
59.99 
0.934 
 
132 
42 
8 
4 
 
28.21 
38.15 
27.95 
37.38 
0.589 
 
132 
42 
8 
4 
 
33.52 
42.83 
29.77 
84.28 
0.359 
 
132 
42 
8 
4 
 
21.59 
27.17 
18.11 
16.90 
0.597 
Frequency of tooth 
brushing: 
Once a day 
Twice a day 
After every meal 
p value 
 
 
91 
57 
5 
 
 
36.94 
39.50 
35.90 
0.880 
 
 
91 
57 
5 
 
 
45.83 
48.61 
75.40 
0.643 
 
 
91 
57 
5 
 
 
33.54 
27.05 
30.48 
0.955 
 
 
91 
57 
5 
 
 
36.67 
23.91 
49.49 
0.488 
 
 
91 
57 
5 
 
 
22.13 
19.89 
48.49 
0.259 
Gum bleeding: 
Yes 
No 
p value 
 
99 
61 
 
36.95 
30.45 
0.412 
 
99 
61 
 
51.23 
36.99 
0.013 
 
99 
61 
 
33.75 
27.50 
0.340 
 
99 
61 
 
37.24 
25.76 
0.063 
 
99 
61 
 
23.20 
17.33 
0.231 
Pain while brushing: 
Yes 
No 
p value 
 
40 
112 
 
42.60 
35.41 
0.292 
 
40 
112 
 
67.64 
38.92 
0.003 
 
40 
112 
 
37.54 
28.46 
0.186 
 
40 
112 
 
40.73 
30.79 
0.080 
 
40 
112 
 
25.75 
22.17 
0.236 
Smoking: 
Yes 
No 
p value 
 
9 
183 
 
45.60 
36.94 
0.914 
 
9 
183 
 
38.70 
49.57 
0.409 
 
9 
183 
 
33.06 
32.51 
0.638 
 
9 
183 
 
37.09 
36.67 
0.895 
 
9 
183 
 
14.74 
22.54 
0.437 
Alcohol consumption: 
Never 
Daily 
Weekly 
Special occasion 
p value 
 
95 
24 
29 
37 
 
 
35.90 
42.96 
38.17 
32.61 
0.735 
 
95 
24 
29 
37 
 
 
46.62 
53.24 
47.81 
44.54 
0.707 
 
95 
24 
29 
37 
 
 
28.72 
38.88 
30.48 
34.80 
0.369 
 
95 
24 
29 
37 
 
 
34.02 
37.59 
37.09 
33.79 
0.828 
 
95 
24 
29 
37 
 
 
22.54 
21.09 
19.52 
23.20 
0.733 
PCR: 
Positive 
Negative 
p value 
 
137 
50 
 
36.94 
41.24 
0.496 
 
54 
133 
 
60.99 
44.38 
0.158 
 
161 
26 
 
33.06 
34.70 
0.861 
 
85 
102 
 
49.48 
32.99 
0.012 
 
82 
104 
 
27.95 
21.78 
0.190 
Gingival inflammation: 
Yes 
No 
p value 
 
82 
104 
 
39.56 
31.82 
0.054 
 
82 
104 
 
51.10 
46.23 
0.389 
 
82 
104 
 
36.67 
27.70 
0.026 
 
82 
104 
 
44.23 
33.07 
0.109 
 
82 
104 
 
25.58 
21.35 
0.054 
Term: 
PLBW 
Normal 
p value 
 
98 
99 
 
27.48 
44.55 
0.002 
 
98 
99 
 
38.77 
59.01 
0.002 
 
98 
99 
 
27.25 
36.86 
0.016 
 
98 
99 
 
26.43 
56.84 
0.000 
 
98 
99 
 
20.90 
26.77 
0.023 
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Table 29: Association between IgM against periodontopathogens and maternal 
history 
Parameters n Pi-IgM 
(Median %) 
n Pg-IgM 
(Median %) 
n Fn-IgM 
(Median %) 
n Aa-IgM 
(Median %) 
n Td-IgM 
(Median %) 
Age in years: 
< 20 years 
21 - 25 
26 - 30 
31 - 35 
≥ 36 
p value 
 
15 
55 
57 
37 
22 
 
17.30 
19.00 
21.93 
20.31 
13.62 
0.777 
 
15 
55 
57 
37 
22 
 
11.41 
13.31 
15.04 
20.90 
15.40 
0.592 
 
15 
52 
57 
37 
22 
 
10.62 
13.45 
16.01 
13.80 
17.11 
0.575 
 
15 
54 
57 
37 
22 
 
-1.53 
7.90 
6.48 
5.29 
8.83 
0.008 
 
15 
54 
57 
37 
22 
 
4.80 
5.88 
5.94 
6.04 
8.82 
0.706 
Education 
No education 
Primary School 
High School 
University 
p value 
 
18 
116 
40 
14 
 
 
17.45 
18.33 
19.85 
34.16 
0.309 
 
18 
116 
40 
14 
 
 
13.30 
13.81 
15.11 
27.29 
0.165 
 
18 
112 
40 
14 
 
 
12.38 
13.91 
15.10 
31.63 
0.273 
 
18 
115 
40 
14 
 
 
0.46 
6.29 
9.55 
9.69 
0.007 
 
18 
114 
40 
14 
 
 
4.41 
5.86 
4.42 
10.78 
0.190 
Dentist Visit frequency: 
Never 
Once a year 
Twice a year 
When ever 
p value 
 
127 
42 
7 
4 
 
18.42 
20.85 
17.39 
31.02 
0.778 
 
127 
42 
7 
4 
 
13.63 
20.90 
12.28 
30.97 
0.118 
 
123 
42 
7 
4 
 
15.47 
13.42 
16.84 
26.53 
0.720 
 
126 
42 
7 
4 
 
6.62 
6.31 
5.20 
8.65 
0.819 
 
125 
42 
7 
4 
 
5.418 
8.69 
5.61 
0.92 
0.196 
Frequency of tooth 
brushing: 
Once a day 
Twice a day 
After every meal 
p value 
 
 
88 
55 
5 
 
 
18.46 
17.30 
30.80 
0.305 
 
 
88 
55 
5 
 
 
16.63 
13.84 
21.08 
0.337 
 
 
84 
55 
5 
 
 
14.10 
12.41 
37.86 
0.128 
 
 
87 
55 
5 
 
 
6.29 
5.29 
8.43 
0.779 
 
 
86 
55 
5 
 
 
5.83 
7.38 
3.98 
0.821 
Gum bleeding: 
Yes 
No 
p value 
 
94 
60 
 
24.28 
14.76 
0.029 
 
94 
60 
 
21.48 
12.88 
0.096 
 
90 
60 
 
15.77 
14.73 
0.427 
 
93 
60 
 
5.40 
8.40 
0.119 
 
92 
60 
 
5.66 
7.922 
0.124 
Pain while brushing: 
Yes 
No 
p value 
 
38 
107 
 
16.13 
20.67 
0.146 
 
38 
107 
 
13.48 
16.53 
0.576 
 
38 
103 
 
13.38 
16.52 
0.219 
 
38 
106 
 
5.10 
7.95 
0.058 
 
38 
105 
 
3.99 
8.15 
0.002 
Smoking: 
Yes 
No 
p value 
 
9 
177 
 
12.95 
19.125 
0.294 
 
9 
177 
 
7.04 
15.04 
0.045 
 
9 
177 
 
12.44 
15.18 
0.379 
 
9 
177 
 
6.22 
6.51 
0.873 
 
9 
177 
 
3.401361 
5.982906 
0.672 
Alcohol consumption: 
Never 
Daily 
Weekly 
Special occasion 
p value 
 
92 
24 
29 
35 
 
15.71 
21.45 
21.03 
24.64 
0.266 
 
92 
24 
29 
35 
 
15.18 
26.00 
10.07 
16.00 
0.110 
 
91 
21 
29 
35 
 
15.18 
15.47 
15.54 
12.62 
0.953 
 
92 
23 
29 
35 
 
5.85 
7.69 
7.96 
6.40 
0.982 
 
92 
22 
29 
35 
 
6.34 
6.65 
5.511 
5.98 
0.643 
PCR: 
Positive 
Negative 
p value 
 
131 
50 
 
18.68 
18.58 
0.624 
 
52 
130 
 
23.92 
12.67 
0.011 
 
153 
24 
 
13.62 
15.36 
0.920 
 
80 
100 
 
5.71 
7.29 
0.096 
 
43 
136 
 
7.10 
5.77 
0.734 
Gingival inflammation: 
No 
Yes 
p value 
 
83 
99 
 
17.23 
20.45 
0.118 
 
83 
99 
 
12.56 
20.00 
0.021 
 
81 
97 
 
12.25 
16.66 
0.057 
 
82 
99 
 
5.44 
7.53 
0.236 
 
82 
98 
 
5.86 
6.34 
0.667 
Term: 
PLBW 
Normal 
p value 
 
92 
99 
 
16.02 
19.37 
0.105 
 
92 
99 
 
14.24 
14.12 
0.907 
 
88 
99 
 
16.90 
12.97 
0.153 
 
91 
99 
 
6.85 
6.40 
0.555 
 
90 
99 
 
7.23 
5.61 
0.058 
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Table 30: Spearman rank correlation between cytokines (IL-6 and IL-10) and IgG 
and IgM against periodontopathogens 
 Maternal blood (MB) Fetal cord blood (FCB) 
IL-6 IL-10 IL-6 IL-10 
Pi-IgG r 
p 
n 
0.110 
0.124 
196 
0.072 
0.316 
196 
0.144 
0.045 
195 
-0.048 
0.502 
196 
Pg-IgG r 
p 
n 
0.092 
0.202 
196 
-0.027 
0.704 
196 
0.003 
0.971 
195 
-0.080 
0.264 
196 
Fn-IgG r 
p 
n 
0.030 
0.681 
196 
0.110 
0.124 
196 
0.128 
0.076 
195 
-0.051 
0.478 
196 
Aa-IgG r 
p 
n 
0.098 
0.170 
196 
0.095 
0.186 
196 
0.068 
0.346 
195 
0.143 
0.046 
196 
Td-IgG r 
p 
n 
0.210 
0.003 
196 
0.051 
0.474 
196 
0.018 
0.800 
195 
-0.124 
0.084 
196 
Pi-IgM r 
p 
n 
0.114 
0.116 
190 
-0.146 
0.044 
190 
-0.024 
0.748 
189 
-0.066 
0.363 
190 
Pg-IgM r 
p 
n 
-0.025 
0.731 
190 
-0.250 
0.001 
190 
-0.099 
0.174 
189 
-0.088 
0.229 
190 
Fn-IgM r 
p 
n 
-0.099 
0.180 
186 
-0.058 
0.430 
186 
-0.043 
0.564 
185 
0.025 
0.732 
186 
Aa-IgM r 
p 
n 
0.072 
0.323 
189 
-0.171 
0.019 
189 
-0.025 
0.730 
188 
0.074 
0.310 
189 
Td-IgM r 
p 
n 
-0.010 
0.889 
188 
-0.030 
0.687 
188 
0.050 
0.496 
187 
0.079 
0.279 
188 
r = coefficient of correlation, p = p value, n = number of patients 
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6.3. DISCUSSION 
 
The objective of this chapter was to evaluate the host immunological response of the 
mother to 5 periodontopathogens and its association with PLBW. In this regard IgG and 
IgM levels were determined in maternal and foetal cord blood samples respectively. 
ELISA test was used for this purpose as described in point 2.4.  
 
A population of low level of education and also a very young population may be exposed 
to periodontal disease due to a lack of proper dental care. In this study only the foetal 
IgM against Aa showed a significant association with age and with level of education.  
 
Gum bleeding and pain when brushing are common indicators of periodontal disease. 
Chronic periodontal infections can produce local and systemic host responses (Gibbs et 
al., 2001). Offenbacher et al., (2006) reported that 40 % of all pregnancies are associated 
with foetal IgM antibody response to periodontopathogens. The presence of specific IgG 
corresponds to maturation of the antibody response while IgM is involved in primary 
response. Reduced IgG in MB offers no protection against infection by that particular 
species while higher levels of IgM indicate that a new infection is present. In this study, 
the lack of maternal (IgG) against P. gingivalis was strongly associated with gum 
bleeding and pain while brushing teeth, while the foetal IgM against P. intermedia and T. 
denticola were associated with gum bleeding and maternal pain during tooth brushing, 
respectively.    
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Ebersol et al., (1982), found that serum antibody levels to suspected periodontopathogens 
are useful markers for periodontal infection. A study by Herminajeng et al., (2001) found 
increased levels of specific IgG antibodies in immunized mice after being challenged 
with live A. actinomycetemcomitans. In the present study, only A. 
actinomycetemcomitans showed a significant association with its specific IgG (p = 
0.012). Madianos et al., (2001) demonstrated an association between FCB-IgM and P. 
gingivalis. In our study, P. gingivalis also showed a significant association (p = 0.011) 
with its specific FCB-IgM. Once again we may interpret that the detection of 
periodontopathogens in these mothers as “carrier” state for these species and that the lack 
of quantification of bacterial load in all of the samples, presents an obstacle in drawing a 
finite conclusion. PCR is a very sensitive detection method for periodontopathogens, 
therefore the risk of detecting a very small number of bacteria in sites which are 
considered to be healthy is also higher (Lee et al., 2003; Klein and Goncalve 2003). 
 
The following associations showed positive correlations: Pi-IgG with IL-6 FCB, Aa-IgG 
with IL-10 FCB and Td-IgG with IL-6 MB while Pi-IgM, Pg-IgM and Aa-IgM showed 
negative correlations with IL-10 MB. In agreement with our findings in chapter 4 
regarding the association of P. intermedia, Aa and the members of the “Red complex” 
with most indicators of periodontal disease used in this study, the specific IgG and IgM 
against the same periodontopathogens are associated with IL-6 and IL-10. 
 
Madianos et al., (2001), found that maternal periodontal infection without protective 
maternal antibody response is associated with the dissemination of periodontopathogens 
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and therefore with PLBW. In this study, significant associations were observed between 
PLBW and IgG against the different peridontopathogens. No significant associations 
were observed between PLBW and IgM against the 5 periodontopathogens but the higher 
levels of IgM were observed in FCB with PLBW. The findings of this study may suggest 
that the low level of maternal IgG and the high level of foetal IgM against the different 
periodontopathogens are associated with dissemination of periodontopathogens to the 
foetal cord thereby suggesting that foetal infection may contribute to PLBW. 
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CHAPTER 7: SUMMARY AND CONCLUSION 
 
The aim of this study was to investigate the association between selected periodonto- 
pathogens and pre-term delivery of low birth weight infants. This aim was reached, firstly 
by recording maternal risk factors which may contribute to preterm delivery of low birth 
weight infants; secondly, by identifying periodontopathogens (Porphyromonas 
gingivalis, Treponema denticola, Prevotella intermedia, Fusobacterium nucleatum, 
Aggregatibacter  actinomycetemcomitans) from maternal gingival crevicular fluid using 
PCR; and thirdly,  by using ELISA to determine the host response (levels of IL-10, IL-6, 
IgG and IgM)  to the above suspected periodontopathic bacteria in MB and FCB 
respectively.  We ommitted to examine GCF for IgG and IgM because there was not 
enough sample available. 
 
Two hundred women who were admitted to the obstetrics and gynecology unit of the 
teaching hospital in Rwanda constituted the sample group for this study. One hundred 
delivered full-term normal weight infants, while the other hundred delivered PLBW 
infants.  
 
Table 31 shows the principle findings of this study, while Table 32 shows a multivariate 
analysis using a logistic regression of risk factors associated with PLBW after adjusting 
for confounding variables.  All factors which were significantly associated with PLBW 
were included in this analysis, except for the health status of the children in the family 
which presented with many missing data. 
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Table 31.  Principle  findings of the study 
ASSOCIATIONS p value 
Pregnancy outcome vs Weight  0.006 
Pregnancy outcome vs Height  0.041 
Pregnancy outcome vs health condition of children in the family  0.003 
Pregnancy outcome vs Previous pre-term birth  0.000 
Pregnancy outcome vs Gingival inflammation and bleeding  0.004 
Pregnancy outcome vs IL-10 MB  0.002 
Pregnancy outcome vs IL-10 FCB  0.000 
Pregnancy outcome vs IL-6 FCB  0.000 
Pregnancy outcome vs Pi-IgG  0.002 
Pregnancy outcome vs Pg-IgG  0.002 
Pregnancy outcome vs Fn-IgG  0.016 
Pregnancy outcome vs Aa-IgG  0.000 
Pregnancy outcome vs Td-IgG  0.023 
Frequency of tooth brushing vs  Pi 0.045 
Gum bleeding vs Pg / Aa 0.041 
Gum bleeding vs Td / Aa 0.032 
Gum bleeding vs Pg / Pi / Aa 0.022 
Gum bleeding vs Td / Pi / Aa 0.032 
Gum bleeding vs Td / Pi / Aa / Fn 0.046 
Signs of gingival inflammation vs Pi 0.013 
Signs of gingival inflammation vs Pg / Pi 0.040 
Signs of gingival inflammation vs Pi / Fn 0.043 
IL-6 MB vs Pi 0.017 
IL-6 MB vs Pi / Fn 0.047 
IL-6 FCB vs Fn 0.037 
Fn-IgG vs Gingival inflammation 0.026 
 Pg-IgG vs Gum bleeding 0.013 
Pg-IgG vs Pain while brushing 0.003 
Aa-IgG vs PCR 0.012 
Pi-IgM vs Gum bleeding 0.029 
Pg-IgM vs PCR 0.011 
Pg-IgM vs Gingival inflammation 0.021 
Td-IgM vs Pain while brushing 0.002 
IL-6 MB vs Td-IgG 0.003 
IL-10 MB vs Pi-IgM 0.044 
IL-10 MB vs Pg-IgM 0.001 
IL-10 MB vs Aa-IgM 0.019 
IL-6 FCB vs Pi-IgG 0.045 
IL-10  FCB vs Aa-IgG 0.046 
 
Factors associated with preterm birth include, amongst others, low maternal body weight, 
maternal smoking and maternal infections (Kramer 2003, Bayingana 2010b). 
Socioeconomic and ethnic factors may account for 50% of the risk for PLBW (Moore et 
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al., 2000; Goldenberg et al., 2000; Hendler et al., 2005; Menon et al 2008, 2010; Velez et 
al 2008) and the remaining risks are deemed to be due to immunologic factors 
(Choudhury and Knapp, 2000). Using bivariate analysis in this study, maternal weight, 
height, history of previous preterm, health status and number of family members, along 
with maternal gingival inflammation, showed a significant relationship with PLBW.  
Smoking and reduced frequency of tooth brushing were significantly associated with Pg-
IgM and Pi-PCR respectively, while maternal level of education, number of previous 
pregnancies, urinary tract infection, sexually transmitted disease, antibiotic 
administration, diabetes, history of heart disease, alcohol consumption and smoking 
showed a positive but not significant relationship with PLBW (Table 31).   
 
Using multivariate analysis, it was demonstrated that mothers weighing ≤ 50 kg, 51-55 
Kg, 56-60 Kg and 61-65 were more likely to deliver PLBW infants than mothers 
weighing > 65kg (Table 32). Maternal height didn’t show significant differences between 
PLBW and FT birth (Table 32). Mothers with a history of previous PLBW were 5.165 
times more likely to deliver PLBW infants in subsequent pregnancies than mothers with 
no history of PLBW infants.  The analysis also shows that mothers with no gingival 
inflammation were less likely to deliver PLBW infants than mothers with gingival 
inflammation (Table 32). 
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Table 32: Multivariate analysis of risk factors associated with PLBW  
 PLBW vs FT 
 OR 95% CI 
WEIGHT (kg) 
> 65 (Reference) 
≤ 50 
51 – 55  
56 – 60  
61 – 65  
 
 
6.150 
7.151 
3.353 
3.132 
 
 
0.698-54.154 
1.086-47.093 
0.735-15.302 
0.664-14.768 
HEIGHT (CM) 
> 165 (Reference) 
≤ 150  
151 – 155  
156 – 160   
160 – 165  
 
 
1.438 
1.153 
0.525 
1.033 
 
 
0.038-2.393 
0.073-3.608 
0.310-8.013 
0.082-3.068 
PREVIOUS PRE-TERM BIRTH 
No (Reference) 
Yes 
 
 
5.165 
 
 
1.524-17.510 
GINGIVAL INFLAMMATION 
Yes (Reference) 
No 
 
 
0.385 
 
 
0.138-1.076 
 
IL-10 MB 
 
1.003 
 
0.997-1.009 
 
IL-10 FCB 
 
1.019 
 
0.993-1.046 
 
IL-6 FCB 
 
1.000 
 
0.996-1.004 
 
Pi -IgG 
 
0.997 
 
0.986-1.007 
 
Pg -IgG 
 
0.995 
 
0.986-1.004 
 
Fn-IgG 
 
0.999 
 
0.978-1.020 
 
Aa-IgG 
 
0.998 
 
0.991-1.004 
 
Td-IgG 
 
1.016 
 
0.991-1.041 
OR: Odds ratio; 95% CI: 95 % confidence interval. 
PLBW =preterm low birth weight; FT = Full term  
 
No significant associations were observed between the PCR detection of the five 
periodontopathogens (and their combinations) and preterm delivery of low birth weight 
infants. Gingival inflammation was significantly associated with combinations of Pi and 
Pg with Fn and Td (Table 31). Aa was found to be an essential element for the significant 
association with gingival bleeding, thus exacerbating the gingival inflammation caused 
by the combinations of periodontopathogens.  One can speculate that the aggressive Aa 
clone referred to in the previous chapter may be associated with this exacerbation.  
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Maternal and foetal immune responses are composed of cytokine expression with a shift 
in the pregnant mother’s immunity from a balanced Th1 and Th2 response to a 
predominant production of Th2 cells which result in the down-regulation of the synthesis 
of cellular immunity and the release of pro-inflammatory cytokines which promote 
antibody production (Fried et al, 1998; Marzi et al., 1996, Mossman and Sad 1996, 
Ugwumado et al, 2002).  IL-6 has been suggested to be an indicator of intrauterine 
infection and a predictor of PLBW (Dudley 1997; Greig et al 1997; Perenyi et al 1999; 
Romero et al 1998; Blidane and Stamatin 2002; Apuzzio et al 2004; Figuera et al 2005; 
Jarocki et al 2007). IL-6 was also found to play a role of diagnostic marker in chronic 
inflammatory periodontal disease (CIPD) (Giannopoulou et al 2003, Atilla et al 1998, 
McGee et al 1998, Wu et al 2001, Quenoz et al 2008, Dashash et al 2008). Elevated 
levels of maternal IL-6 have been associated with SIRS (Systemic Inflammatory 
Response Syndrome), a diagnosis which has been associated with PLBW in the absence 
of early aetiologic organisms (Dudley, 1997). Genotypes of IL-6 were found to be both a 
risk factor for PLBW due to CIPD (Offenbacher et al, 1998) as well as protective against 
intrauterine growth restriction (Dashash et al 2008). 
 
It is not known whether inflammatory cytokines that may trigger PLBW are of foetal or 
maternal origin, nor is it clear whether they are expressed as a cause or consequence of 
PLBW (Elovitz, 2006).  Offenbacher et al., (1999) reported that information regarding 
translocation of periodontopathogens to the fetoplacental interface can be obtained from 
foetal cord serum samples. If inflammation rather than bacterial invasion per se is 
suspected to be the cause of PTB, then it is meaningful to examine for specific 
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inflammatory markers in the mother and neonate. In this study, we examined maternal 
(MB) and fetal cord blood (FCB) for IL-6 and IL-10 levels in order to assess their role as 
indicators of PLBW and their association with selected periodontopathogens implicated 
in preterm delivery. IgG and IgM were also detected in MB and FCB respectively.  
 
Elevated  IL-6 expression in FCB was found to correlate with amniotic fluid levels 
(Romero et al 1998), but not with maternal serum levels of mothers in labour (Jokie et al 
2000, Romero et al 1998;  Skogstrand et al , 2008), indicating that IL-6 does not easily 
cross the placenta and that IL-6 in FCB may be of foetal origin (Aaltonen et al 2005, 
Reisenberger et al 1996, Bhartiya et al 2000), initiating labour along-side inflammation 
of chorioamniotic membranes (Romero et al., 1998).  In this study, we examined FCB for 
IL-6 in order to determine whether foetal inflammation was present before birth, thus 
initiating PLBW. Using the bi-variate analysis, we found that over expression of IL-6 in 
FCB was significantly associated with PLBW (p = 0.000), but no association was found 
between IL-6 MB and PLBW. In the multivariate analysis, no association between IL-6 
in FCB and PLBW was found. Nemes et al. (2009) reported that multivariate analysis 
tends to systematically overestimate odds ratios (OR) when the sample size is less than 
500.  If that is the case, then one has to bear in mind that these results are based on a 
sample size of only 200 mothers. Elevated levels of IL-6 in foetal blood are known to be 
associated with FIRS (Foetal Inflammatory Response Syndrome), the response of the 
foetus to the hostile intrauterine environment (Romero et al., 2007). 
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The relationship between pro- and anti-inflammatory cytokines and maternal gingival 
inflammation could not be clearly established in this study, because F. nucleatum showed 
a significant correlation with IL-6 levels in FCB and when present with P.intermedia, a 
correlation with IL-6 was also observed in MB. Since P. intermedia and F. nucleatum are 
both associated with pregnancy gingivitis (Africa et al 2010) which may add to the oral 
inflammatory burden, thus increasing the risk for PLBW, it was unexpected to find no 
correlation between IL-6 and IL-10 and gingival inflammation in this study.  
 
Contradictions in the literature create confusion regarding the role of IL-10 in PLBW and 
its apparent multifarious role at the maternal – foetal interface remains controversial 
(Blidane and Stamatini 2002, Lin et al 1993, Thaxton et al 2010). Infants are known to 
have a dominant anti-inflammatory cytokine profile (Adkins et al, 2004) that is reported 
to be reduced in PLBW (Dudley 1997, Bayoumi et al 2008) and CIPD (Yamakazi et al 
2001, Gautoudi et al 2004). Others have reported elevated levels of IL-10 with PLBW 
(Matoba et al 2009). In this study (using bivariate analysis), significant associations of 
IL-10 MB and IL-10 FCB were observed with PLBW. Bayoumi et al (2008) recorded IL-
10 FCB to be significantly lower than IL-10 MB or placental sera (p<0.001). No 
significant differences were observed in this study between IL-10 MB and IL-10 FCB 
with PLBW when multivariate analysis was used, although levels were slightly increased 
(Table 32).  
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In summary, this study revealed that: 
a) Positive correlations were found between: 
 Pi-IgG and IL-6 FCB 
 Aa-IgG and IL-10 FCB 
 Td-IgG and IL-6 MB 
b) Negative correlations were found between: 
 IL-10 MB and PI-IgM 
 IL-10 MB and Pg-IgM 
 IL-10 MB and Aa-IgM 
c) IgG to each of the 5 periodontopathogens showed a significant association with 
PLBW 
d) IL-6 FCB, IL-10 MB, IL-10 FCB were all significantly associated with PLBW. 
e) Significant associations were found between Pg-IgG and reduced frequency of 
tooth brushing, as well as between pain and Pg-IgG and Td-IgM (Table 32).  
f) IgM and the 5 periodontopathogens showed no statistical association even 
though higher levels of IgM were observed in FCB of PLBW infants. 
g) A significant association between gingival inflammation and PLBW was 
demonstrated. 
 
As with IL-6, the presence of IgM in FCB signifies foetal synthesis and may be 
considered to be a non-specific indicator of intra-uterine infection. Since IgM does not 
cross the placenta, its presence would demonstrate foetal response to a transplacental 
transfer of oral microbial antigens (Madianos et al, 2008). It can therefore be concluded 
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that foetal exposure to the oral pathogens Pi, Pg and Aa, evidenced by an IgM response 
as well as an inflammatory response (IL-6 FCB, IL-10 FCB), coupled with maternal IgG 
response to the 5 periodontopathogens and the release of inflammatory cytokines (IL-6 
MB and IL-10 MB), all of which,(except IL-6 MB) could be significantly associated with 
PLBW, may provide a mechanism by which maternal periodontopathogens may infect 
the foetus and thus increase the risk for PLBW. The increased expression of 
inflammatory mediators may trigger the release of PGE2   resulting in premature 
contractions in an effort to deliver the foetus from a threatening environment.  
 
Limitations of this study include the crude evaluation of gingival inflammation and 
failure to establish whether the association between levels of inflammatory markers and 
PLBW correlated with the degree of prematurity. Although PCR has often been proposed 
as the new gold standard for detecting pathogens in clinical samples (Edwards et al., 
2003; Klein and Gonçalves, 2003), detection of endogenous microbes (as in the oral 
cavity) can only yield meaningful results if bacterial load is quantified (Ashimoto et al., 
1996; Papapanou et al., 2000).  Also, PCR is a sensitive detection method for 
periodontopathogens, and thus there is a risk of detecting even a very small number of 
bacteria in an otherwise healthy periodontium.  (Klein and Gonçalves, 2003; Africa et al., 
2009; Bayingana et al., 2010a).  
 
With so many contradicting reports regarding the presence and role of the oral anaerobes 
and PLBW, research in this area continues in the quest for conclusive evidence of their 
role in adverse pregnancy outcomes. Some studies show a significant correlation, while 
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others do not (Madianos et al., 2001; Mitchell-Lewis et al., 2001; Dörtbudak et al., 2005; 
Jarjoura et al., 2005; Noack et al., 2005; Skuldbol et al., 2006; Lin et al., 2007).  Factors 
such as race, geographical location and socio-economical standards should be  adequately 
adjusted for and thus studies done in USA and Europe differ from those in Latin America 
or Africa largely because of socio-economic factors such as affordability and easy access 
to adequate health care.   
 
Whether or not to treat pregnant mothers for periodontal disease remains controversial.  
Most interventions to prevent preterm birth have in the past been unsuccessful 
(Michalowicz et al., 2006; Offenbacher et al., 2009; Jeffcoat, 2010; Niederman, 2010), 
and in the few cases that reported success, these are not known to be universally effective 
and are only applicable to a small number of women at risk for preterm birth (Goldenberg 
et al., 1998). The quest for a better understanding of the mechanism leading to preterm 
delivery continues. In the meanwhile, pregnant women are required to fulfill the basic 
rules of proper hygiene and nutrition, weight control and regular visits to dentist and 
gynecologist to ensure that they maintain good health throughout their pregnancies and 
deliver healthy infants. It should be emphasized that this was not an assessment of 
periodontal disease per se although an association was found between the host responses 
to selected periodontopathogens implicated in PLBW. It is viewed that this study has 
paved the way for more detailed examination and assessment of the oral health status of 
mothers with particular emphasis on periodontal disease and its association with adverse 
pregnancy outcomes.  
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Until a fully standardized protocol is available to establish the exact role of periodonto- 
pathogens in PLBW, comparison with other studies will always be hampered by 
differences in diagnosis, sampling and size of sample, detection methods and data 
analysis. This, compounded by differences in race, socio-economic status and 
geographical position may lend itself to speculation and often affect interpretation of 
results in such a way as to favour a proposed hypothesis.  
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APPENDIX TO CHAPTER 2(A) 
Health Risk Assessment Questionnaire 
 
Dear patient, 
 
As part of this study we need to collect information pertaining to your lifestyle so that an 
assessment of your health risks may be made.  Any information contained on this sheet will be 
held in the strictest confidence and I would urge you to respond to the questions with accuracy.   
No details of personal identification will be included for your protection. 
Age………………………...............                                          
Weight of the mother………………              Height of the mother…………………… 
Weight of the new born……………              Term of the new born………………….  
 
1. What is your level of formal education? 
      High school / primary school/ university/ no formal education  
2. Do you live in a House / flat / shack/ homeless 
  
3. How many people share your home? 
  
4. (i)  How long have you been living at your present address? 
           < 5 Years / 5-10 years / >10 years 
5. (i)  How many children do you have ? 
    (ii) Are they healthy? Yes / No 
    (iii)  If No, what is the problem? 
    
 
(iv)  How long has it been? 
6. (i)  Is this your first pregnancy ? Yes / No 
    (ii) If No, how many have you had and did you carry full 
term? Yes / No 
    (iii)  Have you ever had an induced abortion? Yes / No 
    (iv)  What stage of your pregnancy was it terminated? 
            First / second / third trimester 
7. (i) Have any of your children been born preterm or with low 
birthweight ? Preterm / low birthweight  
8. How often do you visit your doctor for gynecological check 
ups? Never /  once a year / only when necessary 
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9.  (i)  Do you have frequent urinary tract infections ? 
           Yes / No 
 
10. (i)  Have you ever had a sexually transmitted disease ? 
            Yes / No 
(ii)  If yes, do you know what it was and was it treated? 
 iii) How many sexual partners have you had? 1/ <5 /5-10/ ›10 
11. (i) Are you diabetic? Yes/No 
      (ii) If yes, what is the duration?............years 
      (iii) Are you being treated for diabetes? Yes/No 
 
12. (i)Do you or any of your family have heart disease?  
          Yes/No 
       (ii) If yes who? 
       (iii) Duration and treatment?...........years  
13. ( i)  How frequently do you visit the dentist ? 
        Never / Once a year / Twice a year /  whenever 
      (ii)  When was the last time you visited a dentist? 
     (iii)  What was the reason? 
     (iv)  Do your gums bleed when you brush your teeth? Yes / No 
      (V)  Do you feel pain when brushing your teeth? Yes / No 
     (v)  How frequently do you brush your teeth? 
           Once a day / twice a day / after every meal 
     (Vi) Do you have bad breath? Yes/ No 
14. Do you have easy access to medical or dental care? 
      Yes / No 
 
15. Do you have medical insurance? 
        Yes / No 
 
16. (i) How often do you have a drink containng alcohol? 
          Never /  daily / weekly/ special occasions 
     (ii) How many drinks would you consume when you do 
drink? 1-2 / 3-5 /  >6 
17. (i)Do you smoke?  Yes / No/ Sometimes 
     (ii)If yes, How many a day? <5  / 5-10 /  >10 
     (iii)How long have you been smoking? <5  / 5-10 />10yrs 
18. (i) What does your diet mainly consist of? 
            Bread / meat / fruit and veg / 
 
19. (i) Did you take antibiotics in past days? Yes/No 
      (ii) If yes when? 
 
Thank you for your participation 
 
 
 
 
 140
APPENDIX TO CHAPTER 2(B) 
CONSENT FORM FOR PARTICIPATION IN RESEARCH PROJECT 
 
Title of Project: A molecular investigation of the prevalence of suspected 
periodontopathogens and their association with preterm birth.  
Names of Researchers: Prof Charlene WJ Africa, Dr Janet Kayitenkore,  
Mr Claude Bayingana (Ph.D student) 
  
If you would like to participate in this study please tick the relevant boxes: 
 
1.  Have you read the attached information sheet and has the purpose of   the research 
project been explained to you?    
2. Do you understand the method of sample collection and any risks involved?  
  
3. Do you grant permission for information from your medical records to be disclosed to 
the research team as and when necessary?    
 
4. Do you agree that samples collected for research or diagnostic testing can be stored for 
possible use in future research projects conducted by the above named researchers  
and /or other research collaborators?   
NO Yes 
Yes NO 
NO Yes 
NO Yes 
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I declare that my participation in this research project is voluntary and that I am free to 
withdraw my approval for use of the sample(s) at any time without giving a reason and 
without my medical treatment or legal rights being affected.   I understand that any 
information contained in my file will remain confidential and that I (or my doctor) will be 
informed if any of the results of the medical tests done (as part of the research) have 
implications for my health.  I know how to contact members of the research team should 
I change my mind about participating in this study.  
 ……………………………                   ……………….                       ……………… 
Name of patient    Date                  Signature 
(BLOCK CAPITALS) 
……………………………              …………………                 ………………. 
Name of person taking consent            Date         Signature 
…………………………  …………………                 ……………… 
Name of researcher     Date              Signature 
THANK YOU FOR AGREEING TO PARTICIPATE IN THIS RESEARCH  
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APPENDIX TO CHAPTER 2(C) 
 
INFORMATION SHEET 
 
Prospective participants are requested to read this information sheet carefully and 
to ask questions where necessary, before signing the attached consent form.  This 
sheet must be detached and retained by the participant and the consent form filed 
for record.   
  
Periodontal infection (gum disease) of the mother may be a potential risk factor for 
preterm low birth-weight (PLBW)). Research data suggests that 18.2 %-50 % of the 
(PLBW) deliveries occurring each year might be attributed to periodontal disease. The 
objective of this study is therefore to asses the relationship between periodontal diseases 
of the mother and PLBW. 
 
The clinical procedure will entail the detection of 5 bacteria most often associated with 
periodontal disease and the measurement of cytokine levels in gingival crevice fluid, 
maternal serum samples and foetal cord serum samples. Specific antibodies (IgG) against 
the above bacteria will be estimated in gingival crevice fluid and in maternal serum. The 
sample collections are safe and will be carried out with the utmost care to ensure the 
comfort of the patient. 
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Patients will be required to sign the attached form granting consent for these procedures 
to be carried out and for the subsequent use of the samples donated and clinical 
parameters recorded.  The patient will also be required to grant permission for her 
medical history to be disclosed. Participants will not be recorded by name, but samples 
and information will be coded to protect the identity of the individual. However, the 
coding will be used by the clinic to trace the individual if relevant information (as a result 
of the study) should be passed to her or her doctor.  Where necessary, participants with 
high level of inflammatory cytokines or participants testing positive for bacteria most 
often associated with periodontal disease, will be referred for treatment. Permission will 
also be sought for the use of additional biological material collected in the clinic, which is 
usually discarded but which the researchers may find useful for future research.  
 
Participation in this study is voluntary and refusal to participate will not prejudice the 
treatment of the patient in any way.  Consent to participate will be recorded by 
completing the attached form.  Should individuals agree to participate and later change 
their minds, they may withdraw by calling the following persons: 
Prof C. Africa, University of the Western Cape, Department of Medical Biosciences, Tel: 
021 959234 or Mr. Claude BAYINGANA, Tel: 0782896940. 
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APPENDIX TO CHAPTER 2(D) 
TES buffer 
 
50 mM Tris hydroxymethyl methylamine 
pH 8.0 
15 mM Ethylenediaminetetra-acetic acid disodium salt. 
91 
 
20 % SDS 
 
20g sodium dodecyl sulfate (SDS) dissolved in 100 ml water. Sterilize by filtration 
through a 0.2 μm filter. 
 
5 M Ammonium acetate 
 
Dissolve 38.54g ammonium acetate in 100ml distilled water. 
 
10X TE : 
 
100 mM Tris-Cl pH 7.5 
10 mM EDT 
For 1 liter: Dissolve 12.11 g Tris and 3.72 g EDTA in around 700 ml distilled water. 
Adjust pH to 7.5 with concentrated HCl. Make volume up to 1 liter. Autoclave. 
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10XTBE 
 
108g Tris, 55g boric acid and 9.3g EDTA. Dissolve and make up to 1 liter. 
 
Ethidium Bromide (EtBr) 
 
Dissolve 0.1 g in 10 ml of water. Shake well to dissolve. Wear gloves and never breath 
the dust. 
 
Loading buffer 
 
0.25% bromophenol blue and 0.25% xylene cyanol in 30% of glycerol in distilled water. 
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APPENDIX TO CHAPTER 2(E) 
 
1. PEPTONE YEAST GLUCOSE (Label with sugar name): 400 ml 
 
- Peptone (Difco Protease peptone No 3)……………………2.0 gr 
- Trypticase Peptone (BBL)………………………………….2.0 gr 
- Yeast Extract (Difco)……………………………………….4.0 gr 
- Resazurin……………………………………………………1.6 ml 
- Salts Solution (VPI Salts)…………………………………..16.0 ml 
- Glucose………………………………………………………4.0 ml 
- Distilled water…………………………………………….400.0 ml 
- Boil on hot plate with chimney till goes yellow 
- Put into ice + CO2 gas with thermometer till 250 C 
- Add vitamin K /Hemin (for sugars)…………………………4.0 ml 
                                           L-cyteine HCL (BDH)……………...0.20 gr 
- pH 6.9 with 8N NaOH 
- Change gas to N2 
- 5 ml per tube 
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2. TRYPTICASE SOY AGAR-CY/DITHIO (TSA-CT): 500 ml 
 
- Trypticase soy Agar (BBL) …………………………………..20.0 gr 
- Yeast extract (DIFCO)………………………………………….2.5 gr 
- Salts Solution (VPI salts)………………………………………20.0 ml 
- Resazurin solution……………………………………………….2.0 ml 
- Distilled water………………………………………………….450 ml 
- Steam and add cysteine/dithio solution (make up fresh)………....5.0 ml 
- Autoclave and add (Vit K/hemin 5.0 m + horse blood 25.0 ml): fridge 
 
3. CYSTEINE/DITHIOTHREITOL SOLUTION (made up fresh) 
 
- BDH Cystein HCL……………………………………0.5 gr 
- Dithiothreitol (fridge)…………………………………0.1 gr 
- Add 10 ml of distilled water 
- Use 5 ml for 500 ml medium 
 
4. Hemin (For plate) 
- hemin (sigma stored at 4o C)…………………………0.5gr 
- N NaOH………………………………………………1.0 ml 
- Add 100 ml of distilled water 
- Autoclave 
- For vit K/Hemin for plates, add 1 ml stock K3. 
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5. Salts solution 
 
- CaCl2 (anhydrous)……………………………………..0.2 gr 
- MgSO4* (anhydrous)…………………………………...0.2 gr 
- K2HPO4……………………………………………….1.0 gr 
- KH2PO4……………………………………………….1.0 gr 
- NaHCO3……………………………………………...10.0 gr 
- NaCl…………………………………………………..2.0 gr 
Mix CaCl2 and MgSO4 in 300 ml distilled water until dissolved. Add 500 ml water and, 
while swirling, slowly add remaining salts. Continue swirling until all these salts are 
dissolved. Add 200 ml distilled water, mix, and store at 4o C. 
or use 0.48 gr MgSO47H2O. 
  
  6. RESAZURIN SOLUTION 
 
 Dissolve 25 mg resazurin in 100 ml distilled water.   
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APPENDIX TO CHAPTER 2(F) 
                               
PREPARATION FOR ELISA REAGENTS: 
 
a. ELISA/ELISPOT Coating Buffer Powder 
 
One packet of ELISA eBioscience Coating Buffer Powder was added and mixed to 1 liter 
distilled water until dissolved, and was filted using a 0.22um filter.    
 
b. Capture Ab: Purified anti-human IL-6 or IL-10 
 
For 1 plate, 20 µl of Ab solution was to 4980 µl coating buffer (Dilution: 1/250) 
 
c. Wash Buffer: 10 X PBS, 0.5 % Tween-20 
 
The following reagents were dissolved in 1 liter dH2O: 
80g NaCl 
2g KCl 
17.7g Na2 HPO4.2H2O 
2.4g KH2PO4 
Add 5ml Tween-20 
One part of the above solution was added to 9 parts of dH2O to make 1XPBS, 0.05% 
Tween-20. 
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d. 5x Assay diluent 
 
To make 1X Assay Diluent, 5 ml of 5X Assay Diluent was added to 20 ml of distilled 
water. This was the working solution for 1 plate. 
 
e. Standard: Recombinant human IL-6 or IL-10 (1 ug/ml) 
 
For 1 plate, 5 µl of standard solution was added to 2500 µl of assay diluent (Dilution: 
1/500) to prepare the top standard solution.  
 
f. Detection Ab: Biotin-conjugate anti-human IL-6 or IL-10  
 
For 1 plate, 20.4 µl of Ab solution was added to 5079.6 µl of assay diluent 
(Dilution:1/25). 
 
g. Enzyme: Adividin-HRP 
 
For 1 plate, 20.4 µl of enzyme solution was added to 5079.6 µl of assay diluent (Dilution: 
1/250). 
 
h. Substrate: 1xTMB solution 
 
Working solution (5000 µl for 1 plate) 
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i. Preparation of the stop solution: 2N Sulfuric acid (H2SO4) 
Slowly add 6mL concentrated H2SO4 to 90mL water. Make to I00mL with water. The 
solution is stable indefinitely.   
Note: Always add acid to water, not water to acid, to avoid excess heat formation and 
spitting of acid. Stir solution when adding acid. 
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   Abstract 
  
Culture has always been recognized as the gold standard for detecting oral anaerobes in 
dental plaque samples. However, many of the bacterial morphotypes observed by 
microscopy are difficult to culture, thus necessitating the need for alternative methods of 
detection. The objective of this study was to evaluate the sensitivity and specificity of 
BANA (N-benzoyl-DL-arginine-B-naphthylamide) and PCR (Polymerase Chain Reaction) 
as reliable detection methods for detecting oral anaerobes such as Porphyromonas 
gingivalis, Tannerella forsythia and Treponema denticola (often referred to as the “red 
complex”) in subgingival dental plaque. Of the 372 samples analysed, 7.25% tested 
positive for the BANA test and 36.29% yielded a positive PCR test. This study showed 
that PCR was more sensitive than BANA in detecting members of the “red complex” in 
plaque samples.  
  
Key words: Polymerase chain reaction (PCR), N-benzoyl-DL-arginine-B-naphthylamide 
(BANA), red complex, subgingival plaque, periodontal disease. 
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APPENDIX H 
Research Paper 
Examination of maternal gingival crevicular fluid for 
the presence of selected periodontopathogens implicated 
in the pre-term delivery of low birthweight infants 
Charlene Africa, Janet Kayitenkore and Claude Bayingana 
Virulence: Volume 1, Issue 4 
July/August 2010; Landes Bioscience 
 
Background: Reports show that more than 20 million infants world-wide are born 
prematurely with 95 % of all pre-term births occurring in developing countries. Oral 
colonization of Gram-negative anaerobes has been implicated as a risk factor for preterm 
delivery of low birth weight infants. 
Materials and Methods: This study comprised 200 women admitted to the department 
of obstetrics and gynecology of the teaching hospital of Butare in Rwanda. Gingival 
crevicular fluid was collected from each quadrant of the mother's mouth (using paper 
points) within 24 hours of delivery.  A dichotomous score of presence or absence of 
gingival inflammation was recorded for each patient along with demographic data such as 
age, marital status etc.  Samples were examined by PCR for the presence of 
Aggregatibacter actinomycetemcomitans and selected members of the red and orange 
complexes described by Socransky et al., (1998), and their presence associated with age, 
gingival inflammation and pregnancy outcomes. 
Results: Association of bacterial species with the risk of periodontal disease and thus the 
risk of preterm delivery was only observed when they occurred in pairs or groups of three 
or more. Aa appeared to be a necessary co-factor for significant associations of bacterial 
groups with the variables recorded.  
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   Abstract 
  
More than 20 million infants in the world (15.5% of all births) are born with low birth 
weight. Ninety-five percent of them are in developing countries. The objective of this 
study was to examine different factors which may contribute to preterm delivery of low 
birth weight (PLBW) in a recent sample of Rwandan birth. The study sample included 
200 randomly selected women admitted to the department of obstetrics-gynecology of 
the teaching hospital of Butare in Rwanda. Mothers were asked to complete a 
questionnaire and obstetrics records were used in order to identify factors which might 
pose a health risk to them and their infants. Maternal weight, height, history of previous 
preterm and healthy conditions of the children in the family showed a significant 
relationship with PLBW. Maternal level of education, number of pregnancies of the 
mother, urinary tract infection, sexually transmitted disease, antibiotic administration, 
diabetes, history of heart disease, alcohol consumption and smoking showed a 
relationship with PLBW but the relationship was not significant. More studies are 
required for a better understanding of the mechanism leading to preterm delivery of low 
birth infants. 
  
Key words: Africa, pregnancy, preterm delivery, low birth weight infants. 
 
 
 
 
 
 
